FlyBase .. Aberrations .. Anatomy .. BLAST .. Genes .. Annotation & Sequences .. Gene Products .. Maps .. People .. References .. Stocks .. Transposons
Help .. Searches .. News .. Site

par-1


REGULATION

Protein Interactions

Wnt signaling regulates ß-catenin-dependent developmental processes through the Dishevelled protein (Dsh). Dsh regulates two distinct pathways, one mediated by ß-catenin and the other by Jun kinase (JNK). A Dsh-associated kinase has been purified from Drosophila that encodes a homologue of Caenorhabditis elegans PAR-1, a known determinant of polarity during asymmetric cell divisions. Treating cells with Wnt increases endogenous PAR-1 activity coincident with Dsh phosphorylation. PAR-1 potentiates Wnt activation of the ß-catenin pathway but blocks the JNK pathway. Suppressing endogenous PAR-1 function inhibits Wnt signaling through ß-catenin in mammalian cells, and Xenopus and Drosophila embryos. PAR-1 seems to be a positive regulator of the ß-catenin pathway and an inhibitor of the JNK pathway. These findings show that PAR-1, a regulator of polarity, is also a modulator of Wnt-ß-catenin signaling, indicating a link between two important developmental pathways (Sun, 2001).

Dsh is progressively phosphorylated in Drosophila during embryonic development. To identify the kinase that phosphorylates Dsh, various domains of Dsh were expressed as glutathione S-transferase (GST)-fusion proteins and tested for their ability to bind the kinase from Drosophila embryos. Only the GST fusion protein containing the middle domain, DM, but not the N-terminal or C-terminal domain of Dsh, has a high affinity for the kinase. The Dsh-associated kinase activity that is precipitated with GST-DM increases as Dsh becomes progressively phosphorylated during development. Similarly, there is a kinase activity present in Dsh immunoprecipitates. An in-gel kinase experiment has shown that the kinase activity, eluted from Dsh immunoprecipitates, is associated with two major bands and a minor band on a polyacrylamide gel. These bands of 110 kDa, 64 kDa and 130 kDa (minor band) are the kinase and its major fragment. The region on Dsh that interacts with the kinase was mapped more precisely to a 36 amino acid segment, DM5, which is N-terminal to the PDZ domain. Importantly, this region in Dsh is well conserved among Drosophila, C. elegans, Xenopus and mammals (Sun, 2001).

Using GST-DM5 precipitation and in vitro phosphorylation as an assay to monitor the Dsh-associated kinase activity, the kinase was purified 60,000-fold from Drosophila embryos and several peptide sequences were then used to clone the cDNA of this kinase. The cDNA clones encoded a protein kinase that is highly homologous to the C. elegans protein PAR-1 (85% identity in the kinase domain and 42% identity overall), which is known to regulate embryo polarity but whose function in Wnt signaling has not been explored (Sun, 2001).

To determine whether dPAR-1 and Dsh form a complex in vivo, endogenous Dsh was immunoprecipitated from Drosophila cells with an affinity purified anti-Dsh antibody and dPAR-1 was detected in the immunocomplex by Western blot using anti-dPAR-1 antibody. These data indicate that dPAR-1 is the kinase responsible for the activity that co-purified with Dsh in the GST pull-down experiment. The PAR-1 protein, prepared by in vitro translation, strongly phosphorylates the middle region of Dsh in vitro. Co-expression of Dsh with wild-type dPAR-1, but not kinase-negative dPAR-1 (dPAR-1 KN), in NIH3T3 cells results in a reduction in Dsh mobility on SDS-PAGE. These data indicate that dPAR-1 directly phosphorylates Dsh in vitro and in vivo (Sun, 2001).

If PAR-1 acts in Wnt signaling, PAR-1 activity might be expected to change in response to Wnt. Drosophila clone-8 cells were stimulated with conditioned medium containing Wingless and it was confirmed that Dsh becomes phosphorylated, and Armadillo is stabilized. The kinase activity of dPAR-1 was also measured under the same conditions. Several experiments have shown that soluble Wg stimulates dPAR-1-specific activity. Wg treatment does not increase the amount of dPAR-1 protein that interacts with GST-DM5. The increased dPAR-1 activity correlates with enhanced Dsh phosphorylation and elevation of Arm levels in Clone-8 cells (Sun, 2001).

To examine whether PAR-1 is required in the Wnt pathway, endogenous PAR-1 activity was suppressed by expressing a kinase-negative PAR-1 (hPAR-1Balpha KN). Chinese hamster ovary (CHO) cells were used because good expression from transfected DNA can be achieved and these cells have a well-characterized response to Wnt. Three hallmarks of Wnt activity were measured: Dsh phosphorylation, ß-catenin stabilization and transcriptional activation. Wnt treatment of CHO cells retards the mobility of Dvl proteins (mammalian homologs of Dsh) on SDS-PAGE, and phosphatase treatment increases the mobility of the Dvl band, thereby confirming that Dvl is phosphorylated in response to Wnt. The hPAR-1Balpha KN suppresses Wnt-mediated phosphorylation of endogenous Dvl proteins, as shown by the reduced amount of a retarded Dvl band. This result is consistent with the data that PAR-1 phosphorylates Dsh in vitro and in cells. Furthermore, both human and Drosophila PAR-1 KN strongly suppress Wnt-induced ß-catenin stabilization. The kinase-negative forms of hPAR-1A, hPAR-1B and hPAR-1C all strongly suppress Wnt-mediated transcriptional activation (measured by LEF1/TCF reporters) in a dose-dependent manner. Importantly, co-expression of wild-type hPAR1 can override the suppression mediated by hPAR-1 KN, indicating that hPAR-1 KN affects Wnt signaling by specifically blocking the effects of endogenous PAR-1 in cells. However, hPAR-1 KN is unable to inhibit the transcriptional activation induced by overexpression of ß-catenin, consistent with PAR-1's role in regulation of Dsh function upstream of ß-catenin (Sun, 2001).

All three human PAR-1 homologs strongly potentiated the responses to Wnt or Dvl3 in CHO cells. The hPAR-1 proteins alone do not activate the signaling pathway but require co-expression of either Wnt or Dvl, indicating that there is synergy between hPAR-1 and other components of the Wnt pathway. The specificity of these responses was verified by their dependency on the co-expression of the LEF1 transcription factor, which is required for Wnt signaling. Furthermore, the effects of hPAR-1 were suppressed by Axin, a negative regulator of the Wnt pathway that acts downstream of Dsh. As predicted, hPAR-1 overexpression does not alter the gene response induced by overexpression of ß-catenin, consistent with the idea that PAR-1 regulates Wnt signaling at a step upstream of Axin and ß-catenin (Sun, 2001).

Dsh also activates an alternative pathway that culminates in the stimulation of JNK in mammalian cells and controls of cell polarity in Drosophila and in vertebrates. Expression of Dvl in NIH3T3 cells induces JNK activation. Interestingly, hPAR-1 strongly suppresses the ability of Dvl3 to activate JNK in NIH3T3 cells. This inhibitory effect depends on the kinase activity of hPAR-1, because a mutation in hPAR-1, which is expected to inactivate its kinase activity (hPAR-1 KN), leads to a loss of its inhibitory effect on JNK activation. Together, these data indicate that PAR-1 promotes the participation of Dsh in the Wnt-ß-catenin pathway but suppresses its function in the JNK pathway, thereby acting as a switch for the downstream responses mediated by Dsh protein (Sun, 2001).

Several studies have shown that Wnt signaling controls axis specification during Xenopus embryogenesis. Ectopic ventral expression of Wnt before the onset of zygotic transcription results in duplication of the dorsal axis: this duplication can be blocked by dominant-negative forms of Frizzled, Dsh and CKIepsilon. Likewise, interference with negative regulators of the Wnt pathway, such as GSK3ß or Axin, by ventral expression of dominant negatives also induces axis duplication. In order to further the understanding of the function of PAR-1 in vertebrates, whether PAR-1 KN can alter Wnt signaling was investigated by injecting PAR-1 RNA into Xenopus embryos. Ventral blastomere injection of XWnt8 RNA results in significant axis duplication, as expected. Co-injection of human or Drosophila kinase-negative PAR-1 RNA significantly inhibits XWnt8-induced axis duplication in injected embryos. Both human and Drosophila kinase-negative PAR-1 can exert functional effects on the Wnt pathway in Xenopus axis duplication experiments (Sun, 2001).

To examine the function of dPAR-1 in Wg signaling in Drosophila embryos, double-stranded RNA-mediated interference (RNAi) was used to generate a dpar-1 loss-of-function phenotype. The ventral epidermis of a wild-type embryo is covered with alternating smooth cuticle and denticle belts. The Wg pathway is required to specify the fate of the epidermal cells that secrete smooth cuticle. RNAi of dpar-1 causes localized ectopic denticle formation and fusion of denticle belts, resembling the wg RNAi phenotype previously described. A similar wg phenotype is also generated with RNAi using double-stranded RNAs derived from different regions of the dpar-1 transcript (Sun, 2001).

Whether Dsh itself or perhaps other proteins bound to Dsh are the most important substrates of PAR-1 remains to be determined. Previous reports have shown that CKIepsilon, a positive regulator of the Wnt pathway, also interacts with Dsh. However, CKIpsilon seems to exert its major effect on more downstream components of the pathway. GBP/Frat (GSK3-binding protein) also interacts with Dsh and has a positive role in the Wnt pathway. Detailed biochemical studies will be required to elucidate the precise function(s) of PAR-1 and its functional interactions with Dsh and other regulators of Dsh in Wnt signaling (Sun, 2001).

Par-1 kinase is critical for polarization of the Drosophila oocyte and the one-cell C. elegans embryo. Although Par-1 localizes specifically to the posterior pole in both cells, neither its targets nor its function at the posterior pole have been elucidated. Drosophila Par-1 is shown to phosphorylate the posterior determinant Oskar (Osk). It has been demonstrated genetically that Par-1 is required for accumulation of Osk protein. In cell-free extracts Osk protein is intrinsically unstable and Osk is stabilized after phosphorylation by Par-1. The data indicate that posteriorly localized Par-1 regulates posterior patterning by stabilizing Osk (Riechmann, 2002).

14-3-3 proteins mediate PAR-1 function in axis formation

PAR-1 kinases are required to determine the anterior-posterior (A-P) axis in C. elegans and Drosophila, but little is known about their molecular function. Drosophila 14-3-3 proteins, 14-3-3epsilon and 14-3-3zeta/Leonardo (Leo) represent the Drosophila homologs of C. elegans PAR-5. 14-3-3 proteins have been identified as Drosophila PAR-1 interactors; PAR-1 binds a domain of 14-3-3 distinct from the phosphoserine binding pocket. PAR-1 kinases phosphorylate proteins to generate 14-3-3 binding sites and may therefore directly deliver 14-3-3 to these targets. 14-3-3 mutants display phenotypes identical to par-1 mutants in oocyte determination and the polarization of the A-P axis. Together, these results indicate that PAR-1's function is mediated by the binding of 14-3-3 to its substrates. The C. elegans 14-3-3 protein, PAR-5, is also required for A-P polarization, suggesting that this is a conserved mechanism by which PAR-1 establishes cellular asymmetries (Benton, 2002).

PAR-1 contains three conserved domains: centrally-located kinase and ubiquitin-associated (UBA) domains, and a C-terminal domain of unknown function. Since the C-terminal domain is dispensable for PAR-1 function in the germline, a yeast two-hybrid screen was performed using a bait containing the kinase and UBA domains. The largest class of preys, representing over 25% of the recovered clones, corresponded to the two Drosophila 14-3-3 proteins, 14-3-3epsilon and 14-3-3zeta/Leonardo (Leo). These interactors represent the Drosophila homologs of C. elegans PAR-5, and this interaction appears to be conserved, since PAR-5 can bind to a fragment of C. elegans PAR-1 (Benton, 2002).

To confirm this interaction by an independent assay, in vitro-synthesized, labeled full-length Drosophila PAR-1 was incubated with bacterially expressed maltose binding protein (MBP)-tagged 14-3-3 proteins bound to amylose beads. Beads containing MBP:14-3-3 fusion proteins, but not MBP alone, efficiently precipitate PAR-1, indicating that this interaction is direct (Benton, 2002).

14-3-3 proteins regulate the activity or subcellular localization of a diverse set of proteins, including several protein kinases, by binding in a phosphorylation-dependent manner to conserved motifs (RSXpSXP or RX1-2pSX2-3pS). Using the yeast two-hybrid system, it was found that 14-3-3 appears to associate with the kinase domain of PAR-1. This contrasts with the interaction of 14-3-3 with other kinases, such as Raf and Wee1, in which 14-3-3 recognizes a phosphoserine-containing motif lying outside the catalytic domain. This interaction with PAR-1 is kinase specific, since 14-3-3 does not bind to the catalytic domains of PKA or aPKC (Benton, 2002).

The region of 14-3-3epsilon that interacts with PAR-1 was determined using the molecular information of three missense alleles of 14-3-3epsilon (Chang, 1997). These alleles were isolated as suppressors of activated Ras or Raf and impair the function of 14-3-3 in Ras/Raf/MAPK signaling. One mutation, E183K, lies within the phosphoserine binding pocket and affects a residue that directly contacts phosphoserine-peptide ligands. The others, F199Y and Y214F, are both located outside this pocket in a hydrophobic region of unknown function. Each of these three mutations were introduced into a 14-3-3epsilon prey clone and their effects on the intermolecular interactions of 14-3-3epsilon were tested (Benton, 2002).

Since 14-3-3 proteins function as dimers, whether these mutations influenced the dimerization property of 14-3-3epsilon was tested. 14-3-3epsilon can form both homodimers and heterodimers with Leo, and none of the three mutations significantly affects these interactions. This is consistent with the location of these mutations in regions distinct from the dimerization interface and indicates that global protein structure and stability are not affected. Interactions were tested of these mutant proteins with a domain of Drosophila Raf that contains a conserved 14-3-3-recognition motif (R740SApSEP745). Raf binds to both Drosophila 14-3-3 isoforms, and the interaction with 14-3-3epsilon is completely abolished by the E183K mutation, but not by the F199Y and Y214F mutations, as expected for an association via the phosphoserine binding pocket (Benton, 2002).

These mutations have opposite effects upon the interaction with PAR-1: E183K does not impair binding, whereas the other mutations either result in a severe (F199Y) or a more modest (Y214F) reduction in the strength of this interaction. These results indicate that 14-3-3epsilon does not bind PAR-1 via its phosphoserine binding pocket, consistent with the lack of canonical binding motifs in PAR-1. The interaction instead appears to be mediated by a novel interface on the external surface of the 14-3-3 molecule. Since the F199 and Y214 residues are conserved in 99% of 14-3-3 sequences, this interface is likely to exist in all isoforms (Benton, 2002).

Since binding of PAR-1 to 14-3-3 should leave the phosphoserine binding pocket vacant, and PAR-1 is a serine/threonine kinase, it was reasoned that PAR-1 might be involved in regulating the phosphorylation-dependent interactions of 14-3-3 with other proteins. Whether PAR-1 can phosphorylate proteins to generate the phosphoserine epitope recognized by 14-3-3 was tested. Using either immunoprecipitated or bacterially expressed PAR-1, efficient phosphorylation was observed of the 14-3-3-interacting portion of Raf. Phosphorylation of Ser743, or the equivalent residue in Raf homologs, is essential for 14-3-3 binding and for Raf function in vivo. This residue was mutated to alanine and this was found to completely abolish the phosphorylation by PAR-1, indicating that PAR-1 specifically phosphorylates Raf to generate a 14-3-3 binding site. This activity of PAR-1 does not require the presence of 14-3-3, and addition of 14-3-3 to this assay does not detectably affect Raf phosphorylation. A mammalian PAR-1 homolog, C-TAK1, is able to phosphorylate proteins such as KSR and Cdc25C within 14-3-3 binding sites, suggesting that this specificity is a conserved property of this kinase family (Benton, 2002).

To test whether 14-3-3 proteins are involved in par-1-dependent processes in vivo, loss-of-function mutations in 14-3-3epsilon and leo were analyzed. Surprisingly, flies homozygous for a protein null allele of 14-3-3epsilon (14-3-3epsilonj2B10) are viable. However, females lay very few eggs, which fail to hatch. Most egg chambers from these females lack differentiated oocytes, as revealed by DNA staining, which distinguishes the oocyte karyosome from the 15 polyploid nurse cells. An identical phenotype is observed in ovaries from flies containing this allele over a deficiency, indicating that the phenotype is specific for this locus. To determine where 14-3-3epsilon is required, clones of this allele were generated in either the germline or somatic follicle cells. Defects in oocyte differentiation were observed only in germline clones; thus, like PAR-1, 14-3-3epsilon is required in the germline for oocyte differentiation (Benton, 2002).

Oocyte determination depends on the MT-dependent transport of specific factors, such as Orb and the germ cell centrosomes, to one cell in the cyst. These factors initially concentrate at the anterior of this cell but subsequently translocate around the nucleus and concentrate along the posterior cortex. This second step appears to require the establishment of a diffuse MTOC along the posterior of the cell and is essential for its stable determination as the oocyte. The formation of this MTOC can be visualized using an antibody to Minispindles (MSPS), a MAP that localizes to sites of MT nucleation. In wild-type egg chambers, MSPS accumulates along the posterior cortex. This accumulation is undetectable in 14-3-3epsilon mutants, indicating that the MTOC has failed to form. Orb and the centrosomes therefore do not undergo the anterior-to-posterior movement and eventually diffuse away as this cell exits meiosis and adopts a nurse cell fate. These phenotypes are indistinguishable from those of par-1 null mutant cysts, indicating that 14-3-3epsilon and PAR-1 function together in this specific step of oocyte determination (Benton, 2002).

In contrast to 14-3-3epsilon mutants, germline clones of a strong lethal allele of leo (leoP1188) display no defects in this process. Since the 14-3-3epsilon phenotype is incompletely penetrant, whether 14-3-3 proteins have partially redundant functions in the germline was tested. Removal of one copy of leo in 14-3-3epsilon mutant clones results in a fully penetrant defect in oocyte determination. Furthermore, removal of one copy of 14-3-3epsilon in leo mutant cysts uncovers an important contribution of leo in this process, since 84% of these cysts display defects in Orb localization. Thus, although 14-3-3epsilon has the predominant function in oocyte determination, Leo can partially compensate in its absence (Benton, 2002).

Polyclonal antibodies against 14-3-3epsilon and Leo were used to examine their localization in the germline. These antibodies are specific, since they do not stain tissue mutant for the corresponding isoform. 14-3-3epsilon is highly expressed in the dividing germline cells in the germarium, and colocalizes with PAR-1 on the fusome, a membranous structure that branches into each germ cell during the early germ cell divisions. The asymmetric partitioning of the fusome during these divisions results in one cell always inheriting more fusome material, which may provide an initial cue to specify this cell as the oocyte. The colocalization of PAR-1 and 14-3-3epsilon on the fusome may therefore represent a mechanism to concentrate these proteins in the future oocyte (Benton, 2002).

At later stages, 14-3-3epsilon colocalizes with PAR-1 at the ring canals, which interconnect the germline cells in each cyst. 14-3-3epsilon can be detected in the cytoplasm and around the cortex of the oocyte but, unlike PAR-1, does not accumulate at the posterior pole. Leo is also expressed in the germline and displays a similar localization to ring canals, but is expressed at very low levels in the germarium (Benton, 2002).

While the fusome and ring canals may represent sites of physical and functional association of PAR-1 with 14-3-3, its localization to these sites is not affected in 14-3-3 mutants, indicating that 14-3-3 binding does not simply act to target PAR-1 to these subcellular destinations. Mutations in the Drosophila PAR-3 homolog Baz cause similar phenotypes in oocyte determination as par-1 and 14-3-3 mutants. However, Baz concentrates at distinct sites in the germarium, in circles around each ring canal that also contain components of adherens junctions, and this localization is not detectably affected in 14-3-3 mutants (Benton, 2002).

The high early cytoplasmic concentration of 14-3-3epsilon has prevented an conclusive determination of whether the fusome localization of 14-3-3epsilon is PAR-1 dependent. However, 14-3-3epsilon is detectable at ring canals in cysts homozygous for a par-1 null allele (Benton, 2002).

To determine if 14-3-3 proteins function with PAR-1 in the repolarization of the oocyte to define the A-P axis, the distribution of osk mRNA and Stau was examined in late-stage egg chambers recovered from homozygous and hemizygous 14-3-3epsilonj2B10 females, and in germline clones of this allele. These mutants display a partially penetrant phenotype, in which osk mRNA and Stau accumulate in dots in the middle of the oocyte. Twenty seven percent of egg chambers display both ectopic and posterior accumulation of osk mRNA and Stau protein, and four percent contain only mislocalized dots. These defects are very similar to those of hypomorphic par-1 mutants and can be strongly enhanced by removal of one copy of par-1 (Benton, 2002).

Although most bcd mRNA localizes normally to the anterior cortex in 14-3-3epsilon mutants, a small proportion is mislocalized along the lateral cortex, and occasionally at the posterior. In contrast to previous observations, such defects in bcd mRNA distribution are also observed in par-1 mutants. These are more pronounced at stages 8-9 than at stage 10, which might reflect a partial recovery in bcd mRNA localization to the anterior between these stages or the diffusion of the mRNA away from the lateral and posterior cortices due to a failure in anchoring. Other mutants that affect the localization of bcd and osk mRNAs, such as gurken, also disrupt the migration of the oocyte nucleus to the dorsal-anterior corner. As in par-1 mutants, however, oocyte nucleus migration appears to be unaffected in 14-3-3epsilonj2B10 mutants (Benton, 2002).

Oocytes that are homozygous for leoP1188 do not display polarity defects. However, strong dominant genetic interactions are observed between 14-3-3 mutants. Thus, these isoforms also function partially redundantly in this process (Benton, 2002).

To gain insights into the basis for the defects in mRNA localization, the organization of the MT cytoskeleton was examined, using a MT plus end marker, Kin:ß-gal. This marker accumulates at the posterior pole in wild-type oocytes, suggesting that the majority of MT plus ends are focused on this site. In contrast, Kin:ß-gal concentrates in the center of 14-3-3epsilon mutant oocytes, indicating that MT plus ends are focused incorrectly, and providing an explanation for the defects in osk mRNA/Stau distribution. The organization of oocyte MTs was directly analyzed using both a FITC-conjugated anti-alpha-tubulin antibody and a Tau:GFP reporter of MT distribution in living egg chambers . In contrast to the wild-type anterior-to-posterior gradient of MTs, 14-3-3epsilon mutants show a uniform distribution of MTs around the oocyte cortex, with the lowest density of MTs in the center. These defects in MT organization are indistinguishable from those of par-1 mutants (Benton, 2002).

The combination of phenotypes in osk and bcd mRNA localization and MT organization is, thus far, unique to par-1 and 14-3-3 mutants, and strongly suggests that they function together in the polarization of the A-P axis (Benton, 2002).

To determine the importance of the 14-3-3 protein interaction domains in vivo, the phenotypes of the 14-3-3epsilon missense alleles, 14-3-3epsilonF199Y and 14-3-3epsilonE183K, were characterized. Neither mutation significantly affects the level or localization of the protein, as assessed by immunostainings. 14-3-3epsilonE183K displays penetrant defects in both oocyte determination and polarization. The penetrance of the latter is almost three times that observed with the protein null allele, indicating that the E183K mutant protein functions as a dominant negative, presumably through the formation of nonfunctional heterodimers with Leo. Thus, the interaction of 14-3-3 dimers with phosphorylated targets is critical for its function in the germline (Benton, 2002).

14-3-3epsilonF199Y mutant egg chambers do not exhibit significant defects in oocyte determination or polarization, consistent with previous reports that this allele only displays phenotypes under genetically sensitized conditions (Chang, 1997). In the absence of leo, however, this allele has a dominant phenotype, with 11% of leoP1188;14-3-3epsilonF199Y/+ egg chambers displaying defects in oocyte determination. Thus, the PAR-1 interaction interface is also important for 14-3-3 function (Benton, 2002).

Thus loss-of-function mutations in 14-3-3 cause phenotypes identical to par-1 mutants in both the initial polarization of the oocyte and the repolarization that defines the A-P axis. These results indicate that 14-3-3 functions as an essential cofactor for PAR-1 in the generation of polarity (Benton, 2002).

Given the diverse roles of 14-3-3 proteins, it is very surprising that the only essential requirement for 14-3-3epsilon is in PAR-1-dependent polarization events in the Drosophila germline. A similar dedication of 14-3-3 function may exist in C. elegans, where animals homozygous for hypomorphic mutations in the 14-3-3 isoform encoded by par-5 are viable but give rise to progeny with highly penetrant defects in the polarization of the A-P axis. Indeed, the discovery that 14-3-3 is required for the initial polarization of the oocyte in the germarium reveals a remarkable homology between the generation of the first A-P asymmetries in flies and worms. Mutations in 14-3-3epsilon give a very specific defect in oocyte determination, in which the oocyte is initially specified correctly but fails to establish a posterior MTOC and to translocate oocyte-specific factors from the anterior to the posterior cortex. This phenotype is identical to that of par-1 null mutants, and the colocalization of PAR-1 and 14-3-3 on the fusome supports the idea that they function together in this process (Benton, 2002).

The Baz/PAR-6/aPKC complex is also required for this step of oocyte determination but localizes to a distinct site in the germarium. Furthermore, it has recently been shown that mutants in the Drosophila homolog of PAR-4 display this phenotype (S. Martin and D.S.J., unpublished data reported in Benton, 2002). Thus, this early polarization of the oocyte requires the Drosophila homologs of five of the six par genes that mediate the A-P polarization of the C. elegans zygote. The final gene, par-2, has no obvious homologs in other organisms and may perform some function that is unique to C. elegans (Benton, 2002).

Although the full complement of PAR proteins is necessary for the initial polarization of the Drosophila oocyte in the germarium, the Baz/PAR-6/aPKC complex does not appear to be required for the repolarization of the oocyte at stage 7. In baz and par-6 null germline clones, a few egg chambers escape the block in oocyte determination, and these complete oogenesis normally, displaying no defects in the localization of Stau to the posterior. Thus, the PAR-1/14-3-3 complex can function to polarize the oocyte independently of these other PAR proteins. PAR-1 also is required for the apical-basal polarity of the follicular epithelium, and localizes to the basolateral domain in these cells. It is interesting to note that 14-3-3epsilon concentrates basolaterally in follicle cells, raising the possibility that it functions with PAR-1 in this process as well. The PAR-1/14-3-3 complex may therefore represent a conserved polarity 'cassette' that plays an analogous role to the Baz/PAR-6/aPKC complex. This requirement is not universal, however, because PAR-1 does not appear to be necessary for the apical-basal polarization of the neuroblasts (J. Kaltschmidt and R. B., unpublished data reported in Benton, 2002), which depends upon Baz, PAR-6, and aPKC. Thus, the two PAR protein complexes may comprise distinct modules that can function either together or separately to generate polarity in different contexts (Benton, 2002 and references therein).

While the common requirement for the PAR proteins strongly suggests that the mechanisms that generate the first A-P asymmetries are conserved between flies and worms, the regulatory relationships between these proteins are not conserved. The hierarchy of PAR protein function in C. elegans has been inferred from the effects of mutants in each par gene on the localization of the other PAR proteins. This analysis places PAR-5 at the top of the hierarchy because it is required for the anterior localization of the PAR-3/PAR-6/PKC-3 complex and the posterior localization of PAR-2 and PAR-1, whereas PAR-1 lies at the bottom because par-1 mutants have little effect on the asymmetric localization of other PAR proteins. In contrast, in Drosophila, Baz and PAR-1 are localized normally in 14-3-3 mutants. Furthermore, although the localization of members of the PAR-3/PAR-6/PKC-3 complex are codependent in the C. elegans zygote, this is not the case in the Drosophila oocyte, nor are they required for the localization of PAR-1 to the fusome. The different positions of PAR-5 and PAR-1 in the C. elegans hierarchy indicate that PAR-5 functions independently of PAR-1 in the localization of the other PAR proteins, but this early requirement makes it difficult to assess whether it is also necessary at other stages in the pathway. The results in Drosophila and the observation that C. elegans PAR-5 and PAR-1 interact in yeast raise the possibility that PAR-5 also functions downstream of PAR-1 (Benton, 2002).

Although the results indicate that PAR-1 and 14-3-3 function together to polarize the oocyte at two stages of oogenesis, the mechanisms by which they generate these polarities are unknown. The repolarization of the oocyte at stage 7 principally affects the organization of the MTs. The original posterior MTOC is disassembled, and the MTs are reorganized to form an A-P gradient, in which most MTs appear to be nucleated from the anterior cortex, with their plus ends extending toward the posterior pole. In 14-3-3 and par-1 mutants the MTs are evenly distributed around the cortex, and a MT plus end marker and osk mRNA/Stau localize to the center of the oocyte. These observations led to the proposal that PAR-1 functions to recruit the plus ends to the posterior. This study shows that par-1 and 14-3-3 mutants also display mislocalization of bcd mRNA around the cortex. Since this mRNA is believed to be transported to the minus ends of MTs, this suggests that MTs are abnormally nucleated from all regions of the oocyte. Thus, PAR-1 and 14-3-3 may also contribute to the generation of the MT gradient by specifically inhibiting MT nucleation along the posterior and lateral cortices. The role of PAR-1 and 14-3-3 in the initial polarization of the oocyte in the germarium is also likely to involve MTs since their loss results in a failure in the formation of an MTOC at the posterior of the cell. The mechanisms that control the formation of this MTOC are not known, however, and it is unclear whether PAR-1 and 14-3-3 function in the same way to polarize the oocyte at both stages (Benton, 2002).

A model for 14-3-3 function with PAR-1 is presented. 14-3-3 proteins regulate the activity of numerous cellular proteins in a phosphorylation-dependent manner by binding as dimers to phosphoserine/threonine-containing motifs. In many cases, this regulation involves sequestration of the target protein in the cytoplasm. For example, 14-3-3 binding to the proapoptotic factor Bad blocks its translocation to mitochondria. 14-3-3 can also directly regulate the activity of its targets: the association of 14-3-3 with serotonin N-acetyltransferase, for example, enhances its ability to bind substrates. The interaction of 14-3-3 with PAR-1 differs from these canonical 14-3-3/target interactions in several respects: (1) the binding of 14-3-3 does not appear to regulate PAR-1 activity, since 14-3-3 mutants have no effect on PAR-1 localization or stability in vivo, or on kinase activity in vitro; (2) the PAR-1 kinase domain lacks both of the well-defined 14-3-3 binding motifs, and interacts with a novel hydrophobic region that is distinct from the phosphoserine binding pocket, which should therefore still be available to bind to other proteins. Thus, 14-3-3 may act as a cofactor for PAR-1 by binding to proteins that are phosphorylated by the kinase. In support of this, it has been demonstrated that PAR-1 can specifically phosphorylate a 14-3-3 binding site in Raf (Benton, 2002).

These observations suggest a model in which PAR-1 has a dual role in regulating 14-3-3/target interactions, first by generating the 14-3-3 binding phosphoepitope, and second by directly delivering 14-3-3 to these sites. Once 14-3-3 is bound to target proteins, its continued association with PAR-1 would maintain the kinase in close proximity to its substrate, which might ensure the stable maintenance of the phosphorylated state (Benton, 2002).

In addition to their role in establishing cell polarity, PAR-1 kinases have been implicated in a diverse range of other cellular processes. The closest mammalian homolog of PAR-1, C-TAK1, was initially purified as an activity that phosphorylates Cdc25C on Ser216. The in vivo significance of this regulation is unknown, but phosphorylation of this site by a distinct kinase, Chk1, induces 14-3-3 binding, and this inhibits Cdc25C as part of the DNA damage checkpoint. C-TAK1 also phosphorylates KSR to promote 14-3-3 binding, which sequesters KSR in the cytoplasm and inhibits EGF signaling. These biochemical activities of C-TAK1 are consistent with the data in Drosophila showing that PAR-1 phosphorylates a 14-3-3 binding site in Raf, and that 14-3-3 mutants give identical phenotypes to par-1 mutants in the germline. The ability to phosphorylate 14-3-3 binding sites may be a general property of PAR-1 kinases, which accounts for the diversity of their functions (Benton, 2002).

Consistent with this, other PAR-1 substrates have been shown to associate with 14-3-3 or contain conserved potential 14-3-3 recognition motifs. The vertebrate PAR-1 homologs, MARK1 and MARK2, were identified as kinases that phosphorylate Tau to inhibit its MT binding ability. 14-3-3 interacts with the MT binding domain of Tau and appears to compete with tubulin for Tau binding. MARK kinase regulation of Tau may therefore be mediated through 14-3-3, which physically blocks the association of Tau with MTs. PAR-1 also phosphorylates the Wingless pathway component Dishevelled. This phosphorylation has been mapped to a 30 amino acid region of the protein, which contains a putative 14-3-3 recognition motif (amino acids 234-242: RTSSYSS) that is essential for its function in planar polarity (Benton, 2002).

The intimate functional relationship between PAR-1 and 14-3-3 raises the possibility that this kinase might be involved in regulating other processes involving 14-3-3 proteins. For example, the observation that PAR-1 phosphorylates Raf to generate a 14-3-3 binding site makes it a candidate for the unidentified kinase that regulates Raf in vivo. In support of this, this study shows that the F199Y and Y214F mutations in 14-3-3epsilon that affect signaling through Raf, impair the interaction of 14-3-3epsilon with PAR-1 (Benton, 2002).

Although many of the activities of PAR-1 kinases may be mediated by inducing 14-3-3 binding, this is probably not the only mechanism by which they act. Drosophila PAR-1 has recently been proposed to have a third function in the germline, in which it phosphorylates, and so stabilizes, OSK protein at the posterior pole of the oocyte to ensure its levels are high enough to specify the germ cells. Unlike PAR-1, 14-3-3 is not detectably enriched at the posterior, suggesting that this function of the kinase might operate via a 14-3-3-independent mechanism. C. elegans PAR-1 may have a similar function in germline specification, through the regulation of P-granule stability, which does not require PAR-5 (Benton, 2002).

A major question is the nature of the target(s) of PAR-1/14-3-3 that mediate their effects on cell polarity. These are unlikely to be any of the known PAR-1 substrates, such as Dishevelled or Tau, since these are not required for axis formation in Drosophila (R. B. and D. S. J., unpublished data reported in Benton, 2002), but the results lead to the clear prediction that they will bind to 14-3-3 in a PAR-1-dependent manner (Benton, 2002).

PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers Tau toxicity in Drosophila

Multisite hyperphosphorylation of tau has been implicated in the pathogenesis of neurodegenerative diseases including Alzheimer's disease (AD). However, the phosphorylation events critical for tau toxicity and mechanisms regulating these events are largely unknown. Drosophila PAR-1 kinase is shown to initiate tau toxicity by triggering a temporally ordered phosphorylation process. PAR-1 directly phosphorylates tau at S262 and S356. This phosphorylation event is a prerequisite for the action of downstream kinases, including glycogen synthase kinase 3 (GSK-3) and cyclin-dependent kinase-5 (Cdk5), to phosphorylate several other sites and generate disease-associated phospho-epitopes. The initiator role of PAR-1 is further underscored by the fact that mutating PAR-1 phosphorylation sites causes a much greater reduction of overall tau phosphorylation and toxicity than mutating S202, one of the downstream sites whose phosphorylation depends on prior PAR-1 action. These findings begin to differentiate the effects of various phosphorylation events on tau toxicity and provide potential therapeutic targets (Nishimura, 2004).

Drosophila has established itself as a model system for studying human neurodegenerative disorders. Fly models of tauopathy have been created by expressing wild-type or FTDP-linked mutant forms of h-tau. Using such models and based largely on overexpression experiments, it has been shown that Shaggy (GSK-3) can promote neurofibrillary tangle (NFT) pathology in photoreceptor neurons (Jackson, 2002). Whether GSK-3 and NFT are necessary for tau-mediated neurodegeneration, however, remains uncertain. Other studies have shown that tau-mediated neurodegeneration could occur without NFT and that GSK-3ß-induced tau hyperphosphorylation in mice could correlate inversely with neuropathology (Nishimura, 2004 and references therein).

Critical testing for a functional role of phosphorylation in tau-mediated neuropathology will require identifying the physiological tau kinase and assessing the consequence of removing this kinase activity on the disease process. Through loss-of-function and overexpression genetic studies and biochemical analysis, it has been shown that PAR-1 is a physiological tau kinase that plays a central role in regulating tau phosphorylation and toxicity in Drosophila. PAR-1 is a Ser/Thr kinase originally identified in C. elegans for its role in regulating cell polarity and asymmetric cell division. PAR-1 homologs have been found in eukaryotes ranging from yeast to mammals and exert essential cellular and developmental functions. MARK kinase, the mammalian homolog of PAR-1, regulates MT dynamics, epithelial cell polarity, and neuronal differentiation. Drosophila PAR-1 plays important roles in MT organization, oocyte differentiation, anterior-posterior axis formation, and Wingless signaling. While analyzing the neuronal function of PAR-1, it was found that Drosophila PAR-1 is a physiological kinase for fly Tau and h-tau. Overexpression of PAR-1 leads to elevated tau phosphorylation and enhanced toxicity, whereas removing PAR-1 function or mutating PAR-1 phosphorylation sites in tau abolishes tau toxicity. Furthermore, an initiator role for PAR-1 has been uncovered in a multisite phosphorylation process that generates pathogenic forms of tau. In this process, phosphorylation by PAR-1 precedes and is obligatory for downstream phosphorylation events, including those carried out by GSK-3 and Cdk5, to generate toxic tau. Consistent with PAR-1 playing an initiator role in the process, mutating PAR-1 phosphorylation sites causes a much more dramatic reduction of overall tau phosphorylation and toxicity than mutating one of the downstream Cdk5/GSK-3 phosphorylation sites. These findings have important implications for understanding the biogenesis of pathogenic tau in neurons and for developing mechanism-based therapeutic strategies (Nishimura, 2004).

To investigate the function of Drosophila PAR-1 in the nervous system, the longest isoform of PAR-1 was overexpressed in the eye using the UAS-GAL4 system. Targeted overexpression of PAR-1 to photoreceptor neurons using the sevenless-GAL4 line resulted in eye degeneration in newly emerged adult flies. Strong PAR-1 expression lines exhibited severely reduced eyes, with fused ommatidia and missing inter-ommatidial bristles, as revealed by scanning electron microscopy (SEM) analysis. Weak or mild expression lines had slightly reduced eyes, which appeared rough and had disordered ommatidia and occasional missing bristles. However, in flies that express two copies of the weak PAR-1 transgene, the eye degeneration phenotype became more severe, similar to that observed in the strong expression line. Thus, overexpression of PAR-1 using the sevenless-GAL4 driver causes eye degeneration in a dosage-dependent manner (Nishimura, 2004).

The degeneration phenotype induced by PAR-1 overexpression could be mediated by abnormal phosphorylation of its substrate(s). MARK kinase was previously shown to phosphorylate tau in vitro. This, together with the fact that expression of h-tau in Drosophila photoreceptor neurons causes similar eye degeneration, led to an investigation of the relationship between tau and PAR-1 in the process. A fly tau homolog was recently shown to be expressed in the nervous system (Heidary, 2001), but no information on its loss-of-function or overexpression phenotype is available. A chromosomal deficiency associated with Tp(3;Y)R97 was used to test possible genetic interaction between endogenous fly tau and PAR-1. Through single embryo PCR analysis, it was confirmed that this deficiency deletes fly tau. In flies overexpressing the strong PAR-1 transgene and heterozygous for the chromosomal deficiency, the eye degeneration phenotype was partially suppressed. This suggests that endogenous fly tau may mediate PAR-1-induced eye degeneration phenotype (Nishimura, 2004).

Possible genetic interaction between fly PAR-1 and h-tau were tested. Overexpression of the four C-terminal tandem repeats (4R) isoform of h-tau containing the R406W mutation (henceforth referred to as h-tauM), which is associated with a familial form of FTDP-17, caused a moderate eye degeneration phenotype. Coexpression of the weak PAR-1 transgene, which by itself had a small effect on eye morphology, enhanced h-tauM toxicity and resulted in smaller sized eyes. The effect of the genetic interaction is also reflected by the extent of photoreceptor neuron loss. PAR-1 and h-tauM coexpressing flies showed a greater neuronal loss than files expressing h-tauM or PAR-1 alone. Interaction between PAR-1 and h-tauM was also observed in cholinergic neurons in the CNS, where coexpression of PAR-1 and h-tauM resulted in profound vacuole formation in both the cell bodies and neuronal processes, whereas expression of h-tauM alone caused only mild vacuole formation in cell bodies and PAR-1 alone had little effect. Thus, elevated expression of fly PAR-1 enhances the toxic effects of h-tauM. Whether PAR-1 and wild-type h-tau genetically interact in the eye was tested. Overexpression of wild-type h-tau also caused a rough eye phenotype. Coexpression of wild-type h-tau and a PAR-1 transgene resulted in an exacerbated phenotype compared to expression of either gene alone. Thus, increased expression of fly PAR-1 enhances the toxic effects of both wild-type and mutant forms of h-tau (Nishimura, 2004).

Recent transgenic animal studies have implicated two kinases, GSK-3 and Cdk5, in the phosphorylation of tau in vivo. Analyses of tau phosphorylation status in transgenic mice overexpressing GSK-3 or Cdk5 have detected increased phosphorylation at certain sites previously identified as their in vitro phosphorylation sites. For example, S202 and PHF-1 sites (S396 and S404) have been shown to be prominent Cdk5 and GSK-3 phosphorylation sites, respectively, and the two kinases may have overlapping specificity at these sites. Tests were performed to see whether these sites in h-tauM were also phosphorylated by the corresponding fly kinases. The activity of Cdk5 is regulated by its binding with neuron-specific activators. Overexpression of Drosophila P35 activator has been shown to elevate endogenous Cdk5 activity. In P35 and h-tauM coexpression flies, the level of phosphorylation at S202 recognized by CP13 antibody is elevated. In addition, phosphorylation at AT270 sites was also significantly increased. Phosphorylation at AT100, AT180, and PHF-1 sites was relatively unchanged. Thus, phosphorylation at S202 and T181 responds to changes in Cdk5 levels. The eye morphology of P35 and h-tauM coexpressing flies appearssimilar to that of flies expressing h-tauM alone, suggesting that elevated Cdk5 activity does not significantly enhance tau toxicity. Shaggy and h-tauM coexpression flies were analyzed next. Coexpression of Shaggy and h-tau results in enhanced eye degeneration phenotypes. In the coexpression flies, significantly increased tau phosphorylation was observed at PHF-1, CP13, AT180, and AT100 sites. It is concluded that these phospho-epitopes contain GSK-3 phosphorylation sites and that elevated phosphorylation at these sites enhances tau toxicity (Nishimura, 2004).

The fact that many of the above-tested phosphorylation sites for GSK-3 and Cdk5 kinases are affected in S2A suggests that phosphorylation by the two kinases is regulated by prior PAR-1 action. To test this idea further, the phosphorylation status of GSK-3 and Cdk5 phosphorylation sites was analyzed in PAR-1 and h-tauM coexpression flies. In addition to 12E8 sites, significant increase of phosphorylation was observed at CP13 and PHF-1 sites in these flies. In contrast, phosphorylation at other sites such as AT100 sites was little changed, suggesting that PAR-1 is not a rate-limiting factor for these phosphorylation events. Since in vitro kinase assays showed that PAR-1 is incapable of directly phosphorylating the CP13 and PHF-1 sites, the elevated phosphorylation at these sites in PAR-1 coexpressing flies are likely mediated by downstream kinases such as Cdk5 and GSK-3 (Nishimura, 2004).

Whether coexpression of PAR-1, GSK-3, or Cdk5 has any modulating effect on S2A toxicity was further tested in vivo. PAR-1 and S2A coexpression flies showed a mild rough eye phenotype similar to PAR-1 overexpression alone, indicating that PAR-1 overexpression does not confer additional toxicity to S2A. Co-overexpression of GSK-3 or Cdk-5 also did not change S2A toxicity. These results further support the notion that phosphorylation by PAR-1 at S262 and S356 is a prerequisite for the subsequent phosphorylation by downstream kinases such as GSK-3 and Cdk5 to generate toxic tau species (Nishimura, 2004).

Since the S2A mutation disrupts tau phosphorylation at multiple downstream sites, it does not allow distinguishing the contribution of individual phosphorylation sites to tau toxicity. This issue was addressed by making point mutations in the downstream phosphorylation sites. Focus was placed on the S202 site because it is phosphorylated by Cdk5 and GSK-3 in vivo and because AT8 antibody, which is sensitive to phosphorylation at this site, was considered an Alzheimer-diagnostic antibody. Transgenic flies were generated that express h-tauM containing an Ala substitution at S202 (S202A). Western blot analysis demonstrated that, as predicted, S202A protein was no longer recognized by CP13 or AT8 antibodies. Significantly, phosphorylation at 12E8, AT100, PHF-1, AT180, and AT270 sites was unaffected by S202A mutation. This suggests that unlike S262 and S356 sites, the phosphorylation state of S202 does not influence that of other sites. Examination of external eye morphology by SEM and photoreceptor staining of eye sections has shown that, unlike S2A, S202A is as toxic as h-tauM. This suggests that phosphorylation by GSK-3 and Cdk5 at S202 site plays a rather limited role in conferring tau toxicity. This result supports the notion that PAR-1 plays an initiator role in the pathogenic phosphorylation process and further suggests that phosphorylation at downstream sites other than S202 or a combination of those downstream phosphorylation events makes a major contribution to tau toxicity (Nishimura, 2004).

Thus PAR-1, the fly homolog of mammalian MARK kinase, plays a central role in conferring tau toxicity in vivo. This study reveals PAR-1 function in triggering a temporally ordered phosphorylation process that is responsible for generating toxic forms of tau. This multisite phosphorylation process involves downstream kinases such as Cdk5 and GSK-3, whose action depends on prior phosphorylation of h-tau by PAR-1. A nonphosphorylatable mutation at S202, one of the downstream GSK-3/Cdk5 target sites whose phosphorylation depends on prior PAR-1 action, has a much smaller impact on overall tau phosphorylation and toxicity than mutations at PAR-1 phosphorylating sites. This strongly supports the initiator role of PAR-1 in generating toxic species of tau and further implies that the toxic form of tau may be phosphorylated at a subset or all of the other downstream sites (Nishimura, 2004).

These results indicate that tau phosphorylation by PAR-1/MARK represents one of the earliest events in the pathological process. Consistent with this notion, the 12E8 epitope sites are phosphorylated in all the isoforms of h-tau found in AD brain. Relatively little is known about the upstream events that act through PAR-1/MARK to regulate h-tau phosphorylation in the disease process. Understanding how PAR-1/MARK kinases are regulated during normal development may provide some clues. PAR-1 belongs to a group of evolutionarily conserved PAR proteins that control cell polarity. Genetics studies have shown that PAR-1 is regulated by a PAR-3/PAR-6/aPKC protein complex. Recently, the mammalian PAR-3 and PAR-6 proteins have been shown to regulate hippocampal neuronal polarity through interaction with the phosphatidylinositol 3-kinase signaling pathway (Shi, 2003). Furthermore, recent biochemical studies have identified a protein kinase capable of activating MARK/PAR-1. It would be interesting to test whether these factors may regulate h-tau toxicity through PAR-1 (Nishimura, 2004).

It was previously shown that PAR-1 regulates the Wingless/Wnt pathway in Drosophila and Xenopus by phosphorylating the core component Dishevelled. It is thus interesting that GSK-3, another core component of Wingless pathway, acts downstream of PAR-1 to phosphorylate h-tau. These results are consistent with the notion that the Wingless pathway may be involved in regulating tau phosphorylation. It has been proposed that the pathway components are utilized differently in tau phosphorylation than in canonical Wnt signaling. The data indicate that PAR-1 and GSK-3 directly phosphorylate tau in an ordered fashion, with PAR-1 action preceding that of GSK-3. One parsimonious explanation for the requirement of prior phosphorylation by PAR-1 is that PAR-1 phosphorylation reduces the affinity of tau for MT and releases it from the MT network, therefore allowing easy access by other kinases. If that is the case, the mechanism may operate in a region-specific manner since certain phosphorylation sites do not depend on prior PAR-1 action. The data are also consistent with the idea that PAR-1 phosphorylation at 12E8 sites provides docking sites for intermediary kinase(s) and/or adaptor molecule(s), which facilitate subsequent phosphorylation by GSK-3 and Cdk5. It appears that the phosphorylation at certain downstream sites is achieved through a complex process. For example, phosphorylation at AT100 sites depends on prior PAR-1 action, but PAR-1 co-overexpression does not increase phosphorylation at these sites. Instead, co-overexpression of GSK-3 can lead to increased phosphorylation at AT100 sites. Previous in vitro studies have shown that the generation of AT100 epitope requires a PHF-like conformation of tau and the sequential phosphorylation by GSK-3 and PKA. It remains to be determined whether GSK-3 and PKA act downstream of PAR-1 to phosphorylate AT100 sites in flies (Nishimura, 2004).

Recent studies suggest that synaptic dysfunction may be one of the earliest events in the pathogenesis of AD. It is reasonable to speculate that abnormally phosphorylated tau may contribute to synaptic dysfunction in AD. MT is known to be essential in synaptic vesicle transport during neurotransmission and in the formation and maintenance of synaptic structures. Given the known function of tau in MT binding, it is conceivable that phosphorylation may induce the detachment of tau from MT, thereby affecting MT dynamics and disrupting synaptic functions. Alternatively, phospho-tau could acquire certain new activities unrelated to MT binding, such as gaining affinity for some unidentified factors at the synapse and interfering with their function. While estimates of the levels of tau phosphorylation at S262/S356 sites (in h-tauM only and h-tauM and PAR-1 coexpression transgenic flies) do not distinguish between these two possibilities, they nevertheless indicate that phospho-tau constitutes a substantial fraction of the total protein. Future genetic studies in Drosopila could help reveal the exact mechanisms of phospho-tau toxicity (Nishimura, 2004).

Rapid progress in an understanding of the biogenesis of amyloid plaques have led to efforts to develop AD therapy based on inhibition of the processing and aggregation of Aß or clearance of mature amyloid plaques. In view of the role of tau in the disease process, it might be more rational to target both amyloid and tau pathologies in therapeutic approaches. This study is beginning to dissect the relative contribution to tau toxicity of individual phosphorylation events. Further analysis will identify the kinases acting downstream of PAR-1 and playing dominant roles in conferring tau toxicity. Future studies will also test whether deregulation of the PAR-1-initiated multisite phosphorylation process may underlie certain idiopathic tauopathies and whether PAR-1 and the downstream kinases could serve as therapeutic targets (Nishimura, 2004).


DEVELOPMENTAL BIOLOGY

Par-1 transcripts are expressed in both the germline and somatic follicle cells throughout oogenesis, but appear to be uniformly distributed at all stages. However, stainings with the Par-1 antisera reveal that the protein localizes to a number of specific sites in both the germ cells and the follicle cells. Par-1 localizes cortically in the follicle cells at early stages, and is restricted to the basolateral membrane domain of the columnar epithelium in stage 10 egg chambers, similar to the distribution of mammalian Par-1 homologs in cultured epithelial cells (Bohm, 1997). The earliest Par-1 staining in the germline is localized to the fusome, a branched structure extending through the ring canals that functions to orient mitotic spindles during the cell divisions in the germarium. As the cysts develop further, Par-1 localizes to the ring canals and the cortical cytoskeleton of the nurse cells. No asymmetric localization has been detected within the oocyte during stages 1-8, but in early stage 9 egg chambers, Par-1 is transiently enriched at the anterior of the oocyte. It then starts to accumulate at the posterior of the oocyte, and becomes progressively more concentrated at the posterior pole during stages 9-10. The posterior localization of Par-1 is very similar to that of the first components of the pole plasm, OSK mRNA and Staufen (Stau) protein, which also show a transient anterior localization before moving to the posterior cortex during stage 9. Indeed, Par-1 colocalizes with a GFP:Stau fusion protein at the posterior of the oocyte. Thus, like its counterpart in C. elegans, Drosophila Par-1 is one of the earliest markers for the posterior pole. The localization of Par-1 cannot be reliably followed at later stages in oogenesis because the chorion blocks antibody penetration, but the protein is not enriched at the posterior of early embryos (Shulman, 2000).

Par-1 and the polarization of the oocyte

After its specification, the Drosophila oocyte undergoes a critical polarization event that involves a reorganization of the microtubules (MT) and relocalization of the determinant Orb within the oocyte. This polarization requires Par-1 kinase and the PDZ-containing Par-3 homolog, Bazooka (Baz). Par-1 has been observed on the fusome, which degenerates before the onset of oocyte polarization. How Par-1 acts to polarize the oocyte has been unclear. Par-1 is shown to become restricted to the oocyte in a MT-dependent fashion after disappearance of the fusome. At the time of polarization, the kinase itself and the determinant BicaudalD (BicD) are relocalized from the anterior to the posterior of the oocyte. Par-1 and BicD are interdependent and require MT and the minus end-directed motor Dynein for their relocalization. baz is required for Par-1 relocalization within the oocyte and the distributions of Baz and Par-1 in the Drosophila oocyte are complementary and strikingly reminiscent of the two PAR proteins in the C. elegans embryo. It is proposed that, through the combined actions of the fusome, MT, and Baz, Par-1 is selectively enriched and localized within the oocyte, where, in conjunction with BicD, Egalitarian (Egl), and Dynein, it acts on the MT cytoskeleton to effect polarization (Vaccari, 2002).

In Drosophila, early oogenesis involves formation of a germline cyst consisting of an oocyte surrounded by 15 nurse cells. The cyst develops in region 1 of the germarium, where a germline stem cell-derived cystoblast divides four times with incomplete cytokinesis and produces a cyst of 16 cells interconnected by the fusome, a continuous membrane-skeletal organelle. The fusome is asymmetrically partitioned into the sibling cells and acts at multiple steps in early oogenesis. During the cyst divisions, it is connected to one spindle pole and guides the cells through an invariant division pattern. Later on, it acts as a scaffold for the migration of the cyst centrosomes into the oocyte, resulting in the organization of a polarized microtubule (MT) network in the cyst. During oocyte determination, the fusome progressively disassembles. In region 2a, the presumptive oocyte, which contains the most fusomal remnants, accumulates determinants such as Bicaudal D (BicD), Egalitarian (Egl), and oo18 RNA binding protein (Orb). Between germarial region 2b and region 3 (also referred to as stage 1 of oogenesis), the oocyte itself becomes polarized, as revealed by the relocalization of Orb from the anterior to the posterior of the oocyte (Vaccari, 2002 and references therein).

Genetic analysis of Drosophila par-1 function has revealed a requirement for the kinase during oocyte polarization; in par-1 null alleles, Orb fails to relocate to the posterior of the oocyte and eventually disappears, after which the oocyte loses its fate and becomes a nurse cell. In addition to Orb, two other oocyte determinants, BicD and Egl, also fail to relocalize within par-1 null oocytes. It has been unclear how Par-1, reported to localize exclusively to the fusome during early oogenesis, could affect the polarization process, which takes place several hours after disappearance of the fusome. D. melanogaster par-1 encodes several isoforms, which are composed of three alternative N termini (N-ter 1–3), a constant kinase, and a spacer domain; they also may include or exclude a C-terminal (C-ter) domain. It was reasoned that the reported Par-1 localization, as revealed by a pan-Par-1 antibody raised against the spacer domain (Par-1 spacer antibody), might only partially reflect the distribution of the kinase. Germline expression of an isoform (N1S) consisting of N-ter 1, the kinase, and the spacer domains and lacking the C-ter allows normal development of par-1 null oocytes. A peptide antibody was raised specifically against N-ter 1 (N1 antibody) and compared the Par-1 signals detected by this antibody and those detected by the original Par-1 spacer antibody. In contrast to the spacer antibody, which detects Par-1 on the fusome, the N1-specific antibody first detects Par-1 in the cyst as the fusome disappears, with the signal becoming restricted to the cytoplasm of the oocyte during its determination in region 2b. This novel Par-1 signal colocalizes with the oocyte marker Orb. The fact that the N1 antibody does not detect Par-1 on the fusome might be explained by a selective accessibility of different domains of the protein. In fact, the N1-specific antibody, which detects Par-1 in the early oocyte, does not recognize fusome-associated Par-1, even in ovaries in which the protein is overexpressed and visible as a GFP fusion on the fusome (Vaccari, 2002).

During oocyte specification, localization of the determinants BicD, Egl, and Orb to the early oocyte relies on the asymmetric distribution of microtubules in the cyst, evident as a dense focus of MT in the oocyte. Depolymerization of the MT by colchicine abolishes the localization of BicD, Egl, and Orb and results in egg chambers with 16 nurse cells and no oocyte. It was therefore asked if the restriction of Par-1 to the oocyte during the transition from region 2a to region 2b is also MT dependent. Ovaries of flies fed with colchicine for 12 hr fail to localize Par-1 and Orb to the oocyte, indicating that Par-1 restriction to the oocyte is indeed MT dependent. This is in contrast to the localization of Par-1 to the fusome, which occurs independently of MT (Vaccari, 2002).

The distribution of Par-1 within the oocyte was further examined by focusing on the transition between regions 2b and 3, when par-1-dependent polarization of the oocyte occurs. In germarial region 2b, Par-1 is enriched anterior to the oocyte nucleus. In region 3, the protein is mainly detected at the posterior of the oocyte, where it remains. During this relocalization, Par-1 colocalizes completely with BicD in the germline. Because par-1 is required for BicD relocalization within the oocyte, the distribution of Par-1 was examined in BicD hypomorphs that allow differentiation of an oocyte. Par-1 is detected but mislocalized in an anterior dot within the BicD mutant oocytes. Hence, Par-1 and BicD are interdependent for their relocalization to the posterior of the oocyte region 3b (Vaccari, 2002).

To assess whether the MT cytoskeleton mediates relocalization of Par-1 and BicD within the oocyte, wild-type ovaries were dissected a short time after treatment with colchicine. A screen was carried out for region 3 egg chambers in which the focus of oocyte MT was destroyed. In these, BicD and Par-1 remain anterior to the oocyte nucleus, indicating that MTs are required for oocyte polarization (Vaccari, 2002).

The MT motor Dynein has been reported to influence development of the germline cyst. Loss-of-function mutants in dhc64C, encoding the heavy chain of the minus end-directed molecular motor Dynein, fail to develop an egg chamber because of mitotic failure in the germarium. However, hypomorphic dhc64C mutants develop an oocyte and 15 nurse cells. In a high percentage of such egg chambers, both Par-1 and BicD remain at the anterior of the oocyte in region 3. Hence, after its initial requirement in cyst formation, the minus end-directed motor Dynein is involved in the relocalization of Par-1 and BicD to the posterior of the oocyte (Vaccari, 2002).

It has been reported that, like Par-1, the D. melanogaster homolog of Par-3 Bazooka (Baz) is necessary for oocyte maintenance. Germline clones of a baz null allele are defective in oocyte polarization, establishing a functional parallel with C. elegans, in which the PAR genes polarize the early embryo. In the worm, restriction of Par-1 activity to the posterior cortex of the embryo crucially depends on Par-3, but the reverse is not the case. In the Drosophila germarium, Par-1 localization to the fusome appears to be independent of Baz. To assess whether the subsequent localization of Par-1 in the oocyte requires Baz, Par-1 distribution was further evaluated in baz germline clones. Par-1 is initially detected at the anterior of the oocyte in region 2b, but the protein disappears in region 3, revealing that Par-1 relocalization is baz dependent (Vaccari, 2002).

The relative distributions of Par-1 and Baz were investigated during later stages of oogenesis in wild-type ovaries. Par-1 is detected at the posterior of the oocyte as of germarial region 3 and becomes tightly associated with the cortex between oogenesis stages 3 and 5. Concomitantly, Baz becomes transiently localized to the anterior of the oocyte. The anterior localization of Baz is specific; it is not observed in germline clones of a baz null allele. Interestingly, maximal expression of Baz at the anterior coincides with the apparent tightening of Par-1 signal at the posterior cortex, suggesting a role for Baz in sharpening Par-1 localization. At this stage, the localization of the two proteins appears to be mutually exclusive. The anterior enrichment of Baz between stages 2 and 5 is absent in germline clones of the par-1 null allele (Vaccari, 2002).

The mutually exclusive distribution of Par-1 and Baz in the Drosophila oocyte is strikingly reminiscent of that observed in the C. elegans embryo. The ability to visualize the two proteins has allowed their respective roles in achieving this distribution to be genetically evaluated. The seeming dependence of Baz localization on par-1 is in contrast to results in C. elegans, in which localization of Par-3 is independent of Par-1. However, the absence of Baz in par-1 germline clones may well reflect the loss of oocyte fate and the onset of its degeneration that occurs at stage 1. Nonetheless, the anterior localization of Baz during stages 2–5 suggests that, after acting in oocyte polarization in region 2b/3, baz may be required again during oogenesis. The existence and nature of such a second requirement for baz after oocyte polarization is not yet clear (Vaccari, 2002).

Research has shown that the fusomal localization of Par-1 is unaffected in baz mutants, suggesting a difference between the Drosophila oocyte and the C. elegans embryo, in which Par-1 localization depends on par-3. Remarkably, at the time when oocyte polarization takes place, baz is in fact required for Par-1 localization within the oocyte. Hence, it appears that a similar relationship exists between Par-1 and Baz at the time when their activities are critical in the two organisms (Vaccari, 2002).

Impairment of the MT cytoskeleton and mutations in BicD and dhc64C also affect Par-1 relocalization within the oocyte. Conversely, in par-1 mutants, the MT cytoskeleton is not focused in the oocyte, BicD fails to relocalize, and Dynein is not enriched in the oocyte. The mutual interdependence of these genes and the MT suggests that all these components cooperate to form a polarization complex in the oocyte. Interestingly, the N1 antibody begins to detect Par-1 only when its function is genetically required, suggesting that, in region 2, the kinase may undergo a change in conformation or in its association with other factors (Vaccari, 2002).

The presence and localization of Par-1 in the oocyte at the time of its determination and polarization complements the previously reported localization of Par-1 on the fusome prior to oocyte determination and establishes Par-1 as a unique oocyte marker, for at least two reasons. (1) Absence of any one of the oocyte determinants, BicD, Egl, or Orb, prevents the concentration of the two other determinants in this cell. In contrast, in the absence of Par-1, it is the relocalization of the determinants within the oocyte that is specifically affected. (2) BicD, Egl, and Orb are not present on the fusome, and the observed enrichment of these determining factors in the oocyte is the result of the enrichment of their RNAs in this cell during its specification. In contrast, no par-1 RNA is detected in the germline at such early stages. The idea that Par-1 is initially loaded on the fusome, where it perdures during the cyst divisions, and that it is later preferentially inherited by the oocyte, is favored. Taken together, the facts that par-1 mutants show no fusomal defects and that accumulation of Par-1 itself in the oocyte requires MT suggest that Par-1 does not affect the oocyte MT cytoskeleton from its fusomal location. It is proposed that, through the combined actions of the fusome, MT, and Baz, Par-1 is selectively enriched and localized within the oocyte, where it acts in conjunction with BicD, Egl, and Dynein to effect polarization (Vaccari, 2002).

Effects of Mutation or Deletion

Given the analogous posterior localization of PAR-1 in the C. elegans zygote and the Drosophila oocyte, an examination of whether Drosophila PAR-1 has a similar role to the nematode gene in the localization of the germline determinants and the polarization of the A/P axis was undertaken. The null allele, par-1W3, is homozygous lethal, and germline clones arrest oogenesis at about stage 5, preventing analysis of its effect on axis formation. The maternal-effect phenotypes were examined of the homozygous viable mutant combinations par-16821/par-16323, par-16323, and par-16323/par-1W3, all of which which reduce the levels of PAR-1 protein without disrupting the function of mei-W68. The progeny of mothers of all three genotypes show typical posterior group phenotypes: the embryos lack abdominal segments, and pole cells fail to form, giving rise to a grandchildless phenotype, in which the adult 'escapers' have agametic gonads. Furthermore, these embryos show little or no Vasa staining at the posterior pole, indicating that the phenotypes arise from a defect in pole plasm formation. The severity of these phenotypes correlates well with the reduction in the levels of Par-1 protein in the mutant ovaries. The strongest mutant combination, par-16323/par-1W3, produces a completely penetrant posterior group phenotype and has the lowest amounts of maternal Par-1, whereas the other mutant combinations express more protein and produce weaker phenotypes. In addition to its requirement for posterior patterning, loss of par-1 causes other less penetrant maternal-effect phenotypes, such as defects in the organization of the head skeleton and telson, and a low frequency of death prior to cuticle deposition, but these appear to be unrelated to its function in A/P axis formation (Shulman, 2000).

A similar ectopic mislocalization of OSK mRNA is observed in mutants such as gurken (grk), Egfr, Pka, and Notch. These mutations disrupt signaling between the posterior follicle cells and the oocyte, resulting in the formation of a symmetric microtubule cytoskeleton that localizes OSK mRNA to the oocyte center and BCD mRNA to the posterior as well as the anterior pole. However, in par-1 oocytes, BCD mRNA localization is indistinguishable from wild type. Furthermore, whereas the oocyte nucleus frequently fails to migrate to the anterior in grk or Notch, it always moves to the correct position in par-1 egg chambers. The localization of GRK mRNA to the dorsal-anterior margin of the oocyte is also unaffected, consistent with the normal dorsal-ventral patterning of par-1 eggs and embryos. Thus, the par-1 mutants cause a novel polarity phenotype, in which the posterior transport of OSK mRNA is redirected to the center of the oocyte, whereas BCD and GRK mRNAs and the oocyte nucleus localize normally at the anterior (Shulman, 2000).

Since the posterior localization of OSK mRNA is dependent on a polarizing signal from the posterior follicle cells, an examination was carried out to see whether these cells are correctly specified in par-1 mutants, and whether Par-1 function is required in the germline or somatic cells of the egg chamber. Unlike grk mutants, in which the 'posterior' follicle cells adopt an anterior fate and express the enhancer-trap line L53b, this line is expressed solely at the anterior in par-16323/par-1W3 egg chambers, indicating that Par-1 is not required for Gurken signaling to the posterior follicle cells. Since germline clones of the par-1 null allele block oogenesis, GFP-marked germline clones of the hypomorphic allele, par-16821, were generated and it was found that Stauffen is mislocalized to the center of the oocyte. In addition, a par-1(N1S) transgene expressed from the germline-specific alpha4-tubulin promoter efficiently rescues the par-16323/par-1W3 OSK mRNA localization and embryonic patterning defects. Thus, par-1 is required autonomously in the germline for the posterior localization of OSK mRNA, and this function must occur after stage 2, when the transgene is first expressed (Shulman, 2000).

The Drosophila homolog of C. elegans PAR-1 becomes asymmetrically localized as polarity is established mutations affecting its expression perturb posterior patterning, germ-line development and posterior localization of pole-plasm components. It is proposed that par-1 has an important and conserved function in the establishment of polarity and development of the germ-line lineage in both of these species (Tomancak, 2000).

Analysis of the distribution of Drosophila PAR-1 in ovaries reveals that it is present in the spectrosome and early fusome of the germarium and becomes enriched in the oocyte during early oogenesis. During stages 5-8 of oogenesis, the protein is uniformly distributed along the oocyte cortex, and at stage 9, it is enriched at the posterior pole, although it can be detected at a low level throughout the oocyte cortex. PAR-1 is also expressed in follicle cells. To determine the role of Drosophila PAR-1, P-element insertions were identified within the genomic region encompassing the par-1 locus and the overlapping mei-w68 locus. Two insertions, l(2)k06323 (par-19A) and l(2)k05603 (par-1574) affect expression of PAR-1 isoforms. Both P elements cause reductions in levels of isoforms of Mr ~110K and lead to increased levels of an isoform of Mr ~116K. Excision of the par-19A P element restores the wild-type expression pattern, demonstrating that these changes are caused by insertion of the P element and confirming the identity of the affected proteins as PAR-1 isoforms. In par-1-mutant egg chambers, distribution of PAR-1 was found to be altered. In stage-9 oocytes, PAR-1 enrichment at the posterior pole is reduced in these mutants; instead the protein appears evenly distributed along the cortex. These changes in PAR-1 distribution presumably reflect changes in the amounts of the various PAR-1 isoforms, as detected by Western blotting (Tomancak, 2000).

Females harboring the par-19A/par-19A and par-19A/par-1574 mutations are fertile; however, 20% of embryos produced by these individuals died, exhibiting defects ranging from disturbances in posterior patterning, such as fusion or bifurcation of segments, to complete absence of abdominal segments. Abdominal patterning in Drosophila is initiated by assembly of the posterior pole plasm, which is also required for formation of the germ-line precursors, the pole cells. In the majority of par-1-mutant embryos, the number of pole cells is significantly reduced, indicating that pole-plasm formation may be affected by par-1 mutations (Tomancak, 2000).

Pole-plasm assembly is induced by localization and translational derepression of oskar messenger RNA at the posterior pole of the oocyte, creating a localized source of Oskar protein, which in turn recruits further pole plasm components. In 70% of par-19A-mutant egg chambers at stages 8-10, oskar mRNA is either fully or partially mislocalized to the middle of the oocyte. This aberrant distribution of oskar mRNA was mirrored by similar defects in localization of Staufen, another pole-plasm component. Moreover, in 20% of stage 8-9 egg chambers, some or all of the Oskar protein detected is found in the middle of the oocyte, indicating that pole-plasm mispositioning may be a cause of defects in abdominal patterning and pole-cell formation (Tomancak, 2000).

Thus, Drosophila PAR-1, like its counterpart in C. elegans, has a function in establishing embryonic polarity, and becomes asymmetrically distributed during the period when polarity is specified. Mutations that alter its expression lead to alterations in the distribution of pole-plasm components, reduced numbers of pole cells and defective posterior patterning. Given the nature of the changes in expression, these defects could result from reduced levels of a critical isoform, inappropriate levels or distribution of an isoform, or a combination of the above (Tomancak, 2000).

Drosophila PAR-1 may influence polarity through the cytoskeleton. Localization of Oskar mRNA to the posterior pole requires both microtubule-dependent and microfilament-dependent processes. The idea that Drosophila PAR-1 regulates microtubules is supported by the fact that mammalian PAR-1 homologs exhibit microtubule-destabilizing activities. In C.elegans, however, there is no evidence of a role for microtubules in par-1-dependent processes, and PAR-1 protein has been shown to interact with non-muscle myosin, an actin motor. Furthermore, proper asymmetric localization of P granules is resistant to microtuble-depolymerizing drugs but sensitive to microfilament-depolymerizing agents. It is therefore also possible that Drosophila PAR-1 acts through a microfilament-dependent mechanism, such as anchoring oskar mRNA and/or OSKAR protein to the posterior pole. Indeed, maintenance of pole-plasm components at the posterior pole of the Drosophila embryo depends on an intact actin cytoskeleton. Previous studies have shown fundamental differences in the early development of Drosophila and C. elegans with respect to establishment of embryonic polarity. In spite of these marked differences, PAR-1 and Drosophila PAR-1, members of the PAR-1/MARK/KIN1 family of Ser/Thr kinases, are distributed asymmetrically at the cell periphery in oocytes and in early embryos of Drosophila and C. elegans, respectively. This finding raises the possibility that at the heart of these two widely divergent systems lies a conserved mechanism to initiate cell polarity and germ-line development (Tomancak, 2000).

Drosophila oocyte determination involves a complex process by which a single cell within an interconnected cyst of 16 germline cells differentiates into an oocyte. This process requires the asymmetric accumulation of both specific messenger RNAs and proteins within the future oocyte as well as the proper organization of the microtubule cytoskeleton, which together with the fusome provides polarity within the developing germline cyst. In addition to its previously described late oogenic role in the establishment of anterior-posterior polarity and subsequent embryonic axis formation, the Drosophila par-1 gene is required very early in the germline for establishing cyst polarity and for oocyte specification. Germline clonal analyses, for which a protein null mutation was used, reveal that Drosophila par-1 is required for the asymmetric accumulation of oocyte-specific factors as well as the proper organization of the microtubule cytoskeleton. Similarly, somatic clonal analyses indicate that par-1 is required for microtubule stabilization in follicle cells. The Par1 protein is localized to the fusome and ring canals within the developing germline cyst in direct contact with microtubules. Likewise, in the follicular epithelium, Par1 colocalizes with microtubules along the basolateral membrane. However, in either case Par1 localization is independent of microtubules. It is concluded that Drosophila par-1 plays at least two essential roles during oogenesis: it is required early in the germline for organization of the microtubule cytoskeleton and subsequent oocyte determination, and it has a second, previously described role late in oogenesis in axis formation. In both cases, par-1 appears to exert its effects through the regulation of microtubule dynamics and/or stability, and this finding is consistent with the defined role of the mammalian Par1 homologs (Cox, 2001).

To investigate the role of Par1 in oogenesis, a polyclonal antibody was generated against a portion of the linker region that is shared by all predicted protein isoforms. Consistent with previous studies, staining with the Par1 antisera reveals that Par1 is expressed in both the germline and the soma. Par1 germline expression is first detectable in the germarium, where it is localized to the fusome, a highly branched structure rich in membrane skeletal proteins such as the Adducin-like hu-li tai shao (hts) gene product. Par1 colocalizes with the fusome component Hts. Subsequently, during cyst development, Par1 colocalizes with actin to the ring canals. In the soma, Par1 is asymmetrically localized to the basolateral membrane of the follicular epithelium. In apical cross section, Par1 is cortically localized in follicle cells, and in transverse sections Par1 is enriched along the basolateral membranes of follicular epithelia. This pattern is highly similar to that observed for the mammalian Par1 homolog MARK, which is also localized basolaterally in cultured epithelial cells. To control for the specificity of the affinity-purified Par1 antisera, Par1 expression was analyzed in homozygous mutant germline and somatic cell clones of a protein null allele (par-1delta16. Par1 basolateral staining is completely eliminated in the mutant follicle cell clones, and fusome and ring canal expression is similarly lost in mutant germline clones (Cox, 2001).

Previous studies of hypomorphic alleles of par-1 have revealed a role in establishing anterior-posterior polarity in egg chambers and subsequent embryonic axis formation. To investigate whether par-1 function is required earlier in oogenesis, a protein null allele was generated in par-1 (par-1delta16). The par-1delta16 allele originates from the imprecise excision of the l(2)k06323 line and is homozygous embryonic lethal. This allele contains a 16 kb deletion removing most of the coding sequences 3' of the P-element insertion; the deletion includes the entire kinase domain and the majority of the linker region. The fact that this allele is embryonic lethal indicates an additional function for par-1 during zygote development. Therefore, to determine the role of par-1 in early oogenesis, mosaic egg chambers were generated whose germline cyst was homozygous mutant for par-1delta16. The FLP/DFS technique was used to generate both par-1 mutant and wild-type germline clones. The germline phenotype of par-1 mutant clones is largely indistinguishable from that of control ovoD females when analyzed by DAPI staining to reveal nuclear morphology. In either case, there are no vitellogenic oocytes observed, and mutant females fail to produce any eggs. These results indicate that par-1 is required early in the germline for oocyte development (Cox, 2001).

To further characterize the germline requirement for par-1 function during oocyte specification, the mosaic analysis was repeated in the absence of ovoD. The FLP/FRT technique was used to generate par-1 mutant germline clones, which are marked by the absence of nuclear GFP expression. Mosaic egg chambers containing homozygous par-1 germline clones were counterstained with the chromatin marker propidium iodide to determine the number and size of the nuclei. Mosaic egg chambers lacking par-1 in germline cells were compared with control egg chambers, which retain par-1 expression in both germline and follicle cells. Control egg chambers invariably contain 15 nurse cells and a single oocyte. In contrast, par-1 mosaic egg chambers contain the normal number of 16 cells; however, all of these cells develop as nurse cells, as indicated by their polyploid nuclei. Mosaic egg chambers that contain wild-type germline cells surrounded by a monolayer of par-1 mutant follicle cells give rise to normal germline cysts of 15 nurse cells and a single oocyte. Phenotypic analysis of germline mosaic egg chambers further reveals a par-1 dependent block at stage 5 to stage 6 of oogenesis. These results taken together clearly demonstrate that par-1 is required in the germline to regulate oocyte differentiation (Cox, 2001).

To analyze how oocyte determination is blocked in par-1 mutant egg chambers, an examination was carried out to see how removing Par1 affects the formation or structure of the fusome and ring canals to which Par1 localizes within the germline. The morphology of fusomes was examined in par-1 mutant cysts by double labeling germaria with nuclear GFP and monoclonal anti-Hts antibody 1B1, a marker for the fusome. In wild-type germaria, a spherical fusome or spectrosome (Sp) is present in germline stem cells and cystoblasts. Following cystoblast division, the fusome (Fu) undergoes a morphogenesis from a spherical fusome in the cystoblast into a polarized, branched structure in the 2-, 4-, 8-, and 16-cell cysts. Analysis of par-1 mutant clones reveals that par-1 is not required for formation of the fusome and that, furthermore, fusome morphology is indistinguishable from wild-type clones within the same germaria. Therefore, while par-1 is not required for fusome formation, the defects in cyst development and oocyte determination suggest that par-1 may nevertheless play an important role as a component of the fusome in establishing and/or maintaining cyst polarity (Cox, 2001).

The ring canals are stable intercellular bridges that maintain the connection between all cells within the 16-cell germline cyst. In wild-type germline cysts, the pattern of ring canal connections is highly invariant; one of the two cells with four ring canals invariably differentiates to form the oocyte, while the remaining 15 cells become nurse cells. Therefore, the pattern of ring canal connections reflects the spatial pattern of the cystoblast mitotic divisions. To analyze the size, formation, and spatial distribution of ring canals in par-1 mutant clones, wild-type and mutant germline cysts and egg chambers stained with rhodamine-conjugated phalloidin were compared to visualize the filamentous actin component of ring canals. In wild-type germaria, each 16-cell germline cyst displays a stereotypic pattern of ring canal connections. In region 2b, when the germline cyst flattens out across the width of the germarium, the spatial distribution of ring canals is manifest as an orderly, linear arrangement across the width of the germline cyst. Similarly, in region 3 of the germarium, the spatial distribution of ring canals remains highly ordered. However, in par-1 mutant germline cysts, the arrangement of ring canals in both region 2b and region 3 of the germarium is disrupted. In region 2b, the wild-type linear distribution of ring canals is clearly disrupted; likewise, in region 3, the arrangement of ring canals appears less ordered and more unevenly distributed. In mosaic egg chambers, the size and location of the ring canal connections is also disrupted. The most posterior germline cell in the egg chamber did not display the typical cluster of the four largest ring canals characteristic of the oocyte. In contrast, in wild-type egg chambers the oocyte is invariantly positioned at the posterior and is easily identified by its four large ring canals at the anterior margin of the cell. Thus, par-1 function is required early in germline cyst formation to establish cyst polarity. Furthermore, the lack of cyst polarity correlates with the failure in oocyte determination that results in the differentiation of 16 polyploid nurse cells (Cox, 2001).

While the precise mechanism of oocyte determination is unknown, one hallmark of this process is the differential accumulation of specific oocyte differentiation factors within a single cell of the germline cyst. A number of these molecules, including Bic-D, Egl, Orb, and Dhc64C, appear to be directly involved in this process since they are required for determination of the oocyte. To further define the role of par-1 in oocyte determination, the expression pattern of these proteins was examined in par-1 mutant germline clones during early and late stages of oogenesis and that expression was compared to wild-type control germaria and egg chambers. In contrast to wild-type germline cysts, par-1 mutant cysts fail to maintain the accumulation of Bic-D protein in a single cell. In region 2b of the germarium, Bic-D protein appears to localize to a single cell; however, this differential localization is not maintained in region 3 of the germarium. Later in oogenesis, par-1 mosaic egg chambers also fail to accumulate Bic-D in a single cell, but rather they display diffuse expression of Bic-D throughout the egg chamber. Similarly, par-1 mutant cysts and egg chambers fail to accumulate Orb, Dhc64C, and Staufen proteins within a single cell. This failure leads to diffuse expression throughout the germline cyst or egg chamber. To investigate the integrity of the microtubule network, oskar mRNA expression was examined in par-1 mosaic egg chambers by in situ hybridization. oskar localization to the future oocyte has previously been shown to require a stable MTOC and microtubule network. In wild-type ovarioles, oskar mRNA is first detected in region 2b, where it begins to accumulate in a single cell. Subsequently, oskar mRNA is localized posteriorly in the oocyte of each developing egg chamber. In contrast, par-1 mosaic egg chambers fail to accumulate oskar mRNA posteriorly. These results indicate that par-1 is required for the differential accumulation of oocyte differentiation factors and further suggests that par-1 may function in establishing and/or maintaining polarity of the microtubule network (Cox, 2001).

In addition to its role in the establishment of axial polarity and the localization of morphogens within the developing oocyte, the microtubule cytoskeleton has a very important role in the early events of oocyte determination. The microtubule cytoskeleton is critical in many aspects of oocyte determination since microtubule depolymerizing drugs disrupt the accumulation of oocyte differentiation factors, such as Bic-D and oskar mRNA, and lead to the development of cysts with 16 nurse cells. Given that par-1 is also required for the differential accumulation of oocyte factors and for oocyte determination, the organization of the microtubule cytoskeleton was analyzed in par-1 mutant clones. In wild-type germaria, the oocyte is characterized by the presence of an active MTOC which organizes the microtubule network within the developing germline cyst. In region 3 of the germarium, the MTOC is clearly present in a single posterior cell. However, in par-1 mutant cysts there is no apparent posterior MTOC formation; rather, the microtubules appear evenly distributed within region 3 of the germarium. Similarly, in stage 2 mutant egg chambers, there is no apparent posterior accumulation of microtubules, but rather the microtubules remain evenly distributed within the mutant cyst. Finally, in later-stage par-1 mosaic egg chambers there remains no posterior accumulation of microtubules or visible MTOC formation. These results indicate that par-1, like Bic-D and Egl, is required for the formation and/or maintenance of an active MTOC within the future oocyte. The even distribution of microtubules within the mutant germline cysts and egg chambers and the failure to maintain an active posterior MTOC may account in part for the defects observed in cyst polarity and, ultimately, oocyte determination (Cox, 2001).

To better understand the relationship between par-1 function and microtubule organization, a detailed analysis was conducted of microtubule structure in par-1 mutant germline clones. To examine the dependence of Par1 localization on an intact microtubule cytoskeleton, adult females were fed with the microtubule depolymerizing drug colchicine. To assay the effect of the drug on disrupting the microtubule cytoskeleton, the production was monitored of egg chambers containing 16 nurse cells and no oocyte and microtubule structure was analyzed by immunofluorescence. In a wild-type germarium, Par1 is expressed on the spectrosome and the fusome, and the microtubules display a highly organized network originating from the posterior MTOC. Following microtubule depolymerization, no disruption was observed in the localization of Par1 to the spectrosome or fusome. This indicates that Par1 localization within the germline is independent of microtubules (Cox, 2001).

Finally, the orientation and attachment of mitotic spindle poles to the fusome during cystocyte divisions is believed to ensure the proper pattern of cell divisions necessary to generate a polarized cyst. Therefore, spindle orientation was examined in dividing par-1 mutant germline cysts. par-1 mutant germline cysts were stained with antibodies to alpha-tubulin and the Hts-related antigen 1B1 to label microtubules and fusomes, respectively. No apparent defect in spindle orientation or attachment to the fusome was found. These results taken together suggest that par-1 regulates microtubule dynamics during cyst formation and oocyte determination by establishing and/or maintaining polarization of the microtubule network (Cox, 2001).

Given that Par1 functions to regulate microtubule dynamics and cyst polarity in the germline, attempts were made to test whether par-1 plays similar roles in the somatic follicle cells. par-1delta16 follicle cell clones were generated and egg chambers were stained to assay both microtubule and epithelial organization as well as follicle cell polarity. par-1 mutant follicle cell clones were examined by double labeling with anti-alpha-tubulin and anti-alpha-Spectrin antibodies to assay microtubule organization and epithelial integrity, respectively. In wild-type follicle cells, alpha-tubulin is normally localized to the basolateral membrane in a pattern very similar to that observed for Par1. However, in par-1 mutant clones, the basolateral alpha-tubulin expression is completely abolished. The effect on alpha-tubulin expression of removing par-1 function is specific since alpha-Spectrin expression is unaffected in par-1 mutant follicle cell clones. Moreover, anti-Spectrin staining reveals defects in epithelial shape and organization. Wild-type follicle cells at this stage form a columnar monolayer that surrounds the oocyte; however, par-1 mutant follicle cells appear to disrupt this monolayer. By using anti-Spectrin staining as a cortical marker, two defects were observed in monolayer organization. (1) It was found that follicle cells lacking Par1 function appear to lose their characteristic columnar shape and appear irregular in size and shape. (2) A disruption was observed in the monolayer such that two follicle cells appear to be stacked on top of one another rather than in a monolayer. This result suggests that disruption in the monolayer may lead to a reorientation or randomization of the plane of division in par-1 mutant follicle cells. An alternative and equally probable interpretation could be that mutant follicle cell division occurs normally; however, following division there may be a reorientation of the mutant follicle cells perpendicular to the wild-type orientation (Cox, 2001).

Since par-1 is required in follicle cells to organize and/or stabilize the microtubule cytoskeleton as well as to maintain the integrity of the epithelial monolayer, the potential role of par-1 in the establishment and/or maintenance of follicle cell polarity was examined. Mutant follicle cell clones were labelled with anti-alpha-tubulin and anti-Armadillo (Arm) antibodies to assay microtubule organization and epithelial polarity, respectively. Armadillo displays a polarized accumulation within follicle cells with intense staining apically in the adherens junctions as well as laterally between cell surfaces. In contrast to the polarized pattern of Arm accumulation in wild-type follicle cells, par-1 mutant follicle cells display an even and slightly weakened distribution of Arm protein. Furthermore, in an apical cross section, it is clear that par-1 mutant follicle cells display a highly disrupted pattern of Arm expression along the cell cortex. These defects in Arm accumulation suggest a loss of polarity within the par-1 mutant follicle cells and further indicate that Par1 may function to organize and restrict the basolateral membrane domain within follicle cells since removing par-1 function leads to a loss of this apical Arm restriction. To further assay the role of par-1 in organizing the basolateral membrane domain, mosaic egg chambers were stained with anti-Neurotactin to assay both apical and lateral membrane integrity. Neurotactin is a transmembrane glycoprotein expressed in epithelial tissues along the apical and lateral membranes. Similar to the effects of par-1 on microtubule stabilization, a dramatic destabilization was observed of both apical and lateral Neurotactin expression in par-1 mutant follicle cell clones. These results taken together strongly suggest that Par1 is required to organize the microtubule cytoskeleton as well as maintain polarity within the follicular epithelium (Cox, 2001).

The PAR-1 kinase is required for the posterior localization of the germline determinants in C. elegans and Drosophila, and localizes to the posterior of the zygote and the oocyte in each case. Drosophila PAR-1 is also required much earlier in oogenesis for the selection of one cell in a germline cyst to become the oocyte. Although the initial steps in oocyte determination are delayed, three markers for oocyte identity, the synaptonemal complex, the centrosomes and Orb protein, still become restricted to one cell in mutant clones. However, the centrosomes and Orb protein fail to translocate from the anterior to the posterior cortex of the presumptive oocyte in region 3 of the germarium, and the cell exits meiosis and becomes a nurse cell. Furthermore, markers for the minus ends of the microtubules also fail to move from the anterior to the posterior of the oocyte in mutant clones. Thus, PAR-1 is required for the maintenance of oocyte identity, and plays a role in microtubule-dependent localization within the oocyte at two stages of oogenesis. PAR-1 localizes on the fusome, and provides a link between the asymmetry of the fusome and the selection of the oocyte (Huynh, 2001a).

To examine the phenotype caused by the complete lack of PAR-1 activity in the germline, the ovoD technique was used to generate clones of par-1W3, a null mutation that deletes most of the par-1-coding region. This technique provides a powerful selection for homozygous mutant clones in the germline, because the ovoD transgene blocks oogenesis at an early stage, so only the mutant clones that have lost the transgene survive. However, no late stage egg chambers were recovered, suggesting that cysts that lack PAR-1 arrest their development before stage 6. Therefore germline clones were induced that were marked by the loss of nuclear GFP, so that the mutant egg chambers could be identified at all stages of oogenesis. Egg chambers with homozygous mutant germlines do develop, but they remain small, and never reach the stage where the oocyte is larger than the nurse cells. The oocyte can be distinguished from the nurse cells early in oogenesis, because it is arrested in meiosis and condenses its chromosomes into a hollow sphere called the karyosome, whereas the nurse cells endoreplicate their DNA to become polyploid. In the mutant egg chambers, none of the cells forms a karyosome, and instead all 16 germ cells become polyploid. The oocyte can also be identified by staining for Orb protein, which localizes in a crescent at the posterior of the cell. Orb does not localize to any of the cells in par-1 mutant egg chambers after stage 3, indicating that mutant cysts develop 16 nurse cells and no oocyte (Huynh, 2001a).

The 16 nurse cell phenotype of par-1 null germline clones is very similar to that produced by mutations in egl and BicD. These mutants disrupt the earliest known step in the selection the oocyte, which is the formation of the synaptonemal complex (SC) in the two pro-oocytes. In egl mutants, all cells in the cyst enter meiosis and reach the pachytene stage, but then lose the SC and revert to the nurse cell pathway of development. In contrast, none of the cells enters meiosis and forms any SC in BicD null germline clones. To see whether par-1 is also required for these early steps, the behavior of the SC was examined in par-1 mutant clones. In contrast to wild type, mutant cysts contain up to 16 cells with SC in early region 2a, indicating that all of the cells have entered meiosis. Unlike egl mutant cysts, however, the SC does not disappear from all cells. Instead, the SC becomes progressively restricted to two cells, and then to one cell in region 3 (also called stage 1). However, this restriction is delayed compared with wild-type cysts, where the SC is always restricted to the oocyte by region 2b. In addition, the SC disappears prematurely from mutant oocytes. Wild-type oocytes retain a compacted SC until stage 3-4, whereas the SC can no longer be detected in mutant stage 2 egg chambers that have just left the germarium (Huynh, 2001a).

This behavior of the SC suggests that par-1 acts at two stages in the germarium: (1) it plays a role in the selection of the pro-oocytes and the oocyte, since too many cells enter meiosis in early region 2a, and the choice of the oocyte is delayed; (2) par-1 is required to keep the oocyte in meiosis after stage 1, since the SC is not maintained (Huynh, 2001a).

The restriction of the SC to one cell suggests that at least some of the initial steps in oocyte determination still occur in par-1 clones. The behavior of other early oocyte markers was examined: the oocyte-specific cytoplasmic protein Orb and the centrosomes. In wild-type cysts, Orb protein accumulates in the pro-oocytes in region 2a of the germarium, and then concentrates at the anterior of the oocyte in late region 2a. As the cyst enters region 3, Orb moves from the anterior to the posterior of the oocyte, and forms a crescent at the posterior pole. The same movement has been reported for a BicD-GFP fusion protein. In par-1 mutant cysts, Orb protein still accumulates in one cell, but this localization is delayed until region 3 (stage 1), like the restriction of the SC. Furthermore, Orb never translocates to the posterior of the oocyte, and the protein disappears from the oocyte by stage 2 (Huynh, 2001a).

The migration of the centrosomes from the nurse cell to the oocyte can be followed by staining for gamma-tubulin. Like Orb, the centrosomes localize to the anterior of the oocyte in region 2b. They then move from the anterior to the posterior of the oocyte in region 3, and coalesce to form a bright dot at the posterior pole. In par-1 mutant clones, the centrosomes accumulate at the anterior of the oocyte in late region 2b or early region 3, indicating that the first phase of centrosome migration occurs normally. The centrosomes remain at the anterior, however, and never translocate to the posterior (Huynh, 2001a).

These results indicate that the loss of par-1 blocks oocyte determination at a novel step. The initial selection of the oocyte occurs normally, since three independent oocyte markers, the SC, Orb and the centrosomes, still accumulate in one cell, but the identity of this cell is not fixed, and it soon reverts to the nurse cell pathway of development. This reversion to the nurse cell fate correlates with a defect in the migration of Orb and the centrosomes from the anterior to the posterior of the oocyte, suggesting that this PAR-1-dependent A-P movement is required for the maintenance of oocyte identity (Huynh, 2001a).

PAR-1 is required for the correct organization of microtubules in the oocyte at stage 9, whether this early phenotype in oocyte determination is also a consequence of a defect in the microtubule cytoskeleton was also examined. In a wild-type germarium, the microtubule cytoskeleton becomes progressively polarized in region 2 and is clearly focused on one cell in late region 2b. par-1 mutant clones stained for alpha-tubulin show a slight delay in the focusing of the microtubules to one cell in region 2b, which is similar to the delay in Orb restriction. However, the overall organization of the microtubules in region 2 appears essentially normal (Huynh, 2001a).

Since it is difficult to interpret the organization of the microtubules within the oocyte in anti-tubulin stainings, markers for the minus-ends of the microtubules were used to examine the polarity of these microtubules in wild type and par-1 mutant cysts. Although the centrosomes lie at the minus ends of the microtubules in most cells, this is not necessarily the case in the germline, since they appear to be inactivated when the cyst leaves region 1, and a Nod-GFP transgene was therefore used as an alternative marker for the minus ends. Nod-GFP localization in wild-type cysts reveals that the minus ends are first focussed at the anterior of the oocyte, before switching to the posterior as the cyst buds off the germarium. In par-1 mutant cysts, Nod-GFP still becomes restricted to the anterior of one cell, but never re-localizes to the posterior (Huynh, 2001a).

Furthermore, the minus end-directed motor, dynein, shows an identical behavior as that of Nod-GFP: it localizes to the anterior of one cell in mutant cysts, but fails to switch to the posterior in region 3. Thus, par-1 is required for a reorganization of the microtubule cytoskeleton of the oocyte in region 3, and this may account for the failure of Orb and the centrosomes to move from the anterior to the posterior of the cell (Huynh, 2001a).

The par-1 null allele is also mutant for mei-W68, which shares a promoter with par-1 and lies entirely within its first intron. Since Mei-W68 is required for the dsDNA breaks that initiate meiotic recombination, some or even all of the phenotypes of par-1 clones could therefore be due to this meiotic defect rather than the loss of par-1 itself. To distinguish between these possibilities, the Gal4/UAS system and a Nanos-Gal4-VP16 driver were used to express the N1S isoform of par-1 in the germarium as a GFP-fusion protein, to determine whether it could rescue the phenotype of par-1W3 germline clones. The fusion protein localizes to a branched structure in regions 1 and 2 of the germarium, which is presumably the fusome, as the endogenous protein is a component of this structure. More importantly, PAR-1N1S completely rescues the delay in Orb localization to the oocyte in par-1W3 homozygous cysts, and also restores the anterior-posterior movement of Orb within the oocyte in region 3. Furthermore, this construct rescues the posterior movement of the centrosomes, and the maintenance of oocyte identity. Thus, these phenotypes are specific to par-1, and are not due to the reduction in Mei-W68 activity or any other mutations on the par-1W3 chromosome (Huynh, 2001a).

The N1L isoform of PAR-1, which differs only from N1S by the exclusion of five amino acids in an alternative exon in the linker region of the protein and the presence of the conserved C-terminal par-1 domain, was also expressed. The PAR-1N1L fusion protein also localizes to the fusome, but is unable to rescue any of the early defects in par-1W3 germline clones, although it is functional because it rescues the par-1 phenotype at other stages of development. This suggests that the par-1 domain inhibits the early function of the kinase, and provides the first example where different PAR-1 isoforms have different activities (Huynh, 2001a).

The GFP-PAR-1 localization in the germarium is intriguing, since it has been suggested that the fusome provides the initial cue for the determination of the oocyte. To confirm that par-1 is recruited to the fusome, wild-type germaria were stained for PAR-1, using an antibody that recognises all isoforms of the protein, and Hu li tai shao (Hts), an integral component of the fusome. PAR-1 and Hts co-localize on the spectrosome, which is the precursor of the fusome in the germline stem cells and cystoblasts, and on the fusome itself. This co-localization is most apparent in region 1, but some PAR-1 persists on the fusome in region 2. In addition, the PAR-1 antibody labels small particles that do not contain Hts, but this is due to a cross-reacting antigen, because these are not seen with the GFP-PAR-1 fusions, and do not disappear in par-1 null germline clones (Huynh, 2001a).

Mutants in other components of the fusome, such as Hts and alpha-Spectrin, produce cysts with fewer than 16 nurse cells, because the precise pattern of cyst divisions is disrupted. However, all par-1W3 mutant egg chambers contain 16 cells, indicating that par-1 is not required for this function of the fusome. To rule out the possibility that the lack of an effect on the pattern of divisions in the cyst is due to the perdurance of wild-type PAR-1 protein in mutant clones, mutant egg chambers derived from persistent stem cell clones that were induced 10 days earlier, were also analysed and the same result was obtained. To test if par-1 affects the formation or morphogenesis of the fusome, mutant cysts were stained for alpha-Spectrin, which is a component of the spectrosome and the fusome at all stages of its development. The spectrosome is asymmetrically partitioned during stem cell division, so that two-thirds remain in the daughter stem cell, and one-third in the cystoblast, and this asymmetry is unaffected in par-1W3 clones. Furthermore, the fusome is asymmetrically partitioned at each subsequent division, as in wild type: when a mutant cystoblast divides, one cell still inherits more fusome than the other; this asymmetry is maintained throughout the next three mitoses, and can be seen in four-cell cysts and in 16-cell cysts that have stopped dividing. Thus, PAR-1 localizes on the fusome, but is not required for its formation or its asymmetric segregation (Huynh, 2001a).

The re-localization of cytoplasmic markers in region 3 reveals the earliest known A-P polarity within the oocyte. It is very intriguing that PAR-1 is required both for this polarization, and the later polarization of the oocyte at stage 9. This raises the question of whether the two are linked. For example, it is possible that the altered organization of the microtubules and mislocalization of Oskar mRNA at stage 9 in par-1 hypomorphs is a consequence of earlier problems in the polarization of the oocyte in the germarium. This seems unlikely, however, for several reasons. (1) The localization of all known markers for oocyte polarity changes during stage 7, suggesting that the early polarization of the oocyte is erased when it re-polarizes in response to a signal from the posterior follicle cells. (2) In the vast majority of egg chambers that are mutant for par-1 hypomorphs, Orb protein moves normally from the anterior to the posterior of the oocyte, and is maintained there as it is in wild type. Furthermore, the Oskar mRNA localization defect of these mutants can be rescued by a par-1 transgene that is only expressed after the cysts have left the germarium. The view that PAR-1 plays a role in the anterior-posterior polarization of the oocyte at two stages of oogenesis is therefore favored. It will be interesting to determine whether these processes are related in other ways, and whether PAR-1 serves a common function in oocyte determination and Oskar mRNA localization (Huynh, 2001a).

The anterior-posterior axis of C. elegans is defined by the asymmetric division of the one-cell zygote, and this is controlled by the PAR proteins, including PAR-3 and PAR-6 (see Drosophila par-6), which form a complex at the anterior of the cell, and PAR-1, which localizes at the posterior. PAR-1 plays a similar role in axis formation in Drosophila: the protein localizes to the posterior of the oocyte and is necessary for the localization of the posterior and germline determinants. PAR-1 has recently been shown to have an earlier function in oogenesis, where it is required for the maintenance of oocyte fate and the posterior localization of oocyte-specific markers. The homologs of PAR-3 (Bazooka) and PAR-6 are also required to maintain oocyte fate. Germline clones of mutants in either gene give rise to egg chambers that develop 16 nurse cells and no oocyte. Furthermore, oocyte-specific factors, such as Orb protein and the centrosomes, still localize to one cell but fail to move from the anterior to the posterior cortex. Thus, PAR-1, Bazooka, and PAR-6 are required for the earliest polarity in the oocyte, providing the first example in Drosophila where the three homologs function in the same process. Although these PAR proteins therefore seem to play a conserved role in early anterior-posterior polarity in C. elegans and Drosophila, the relationships between them are different, since the localization of PAR-1 does not require Bazooka or PAR-6 in Drosophila, as it does in the worm (Huynh, 2001b).

The determination of the oocyte can be followed by the migration of the centrosomes, which move along the fusome to cluster at the anterior of the oocyte in region 2b, and then translocate to the posterior of the oocyte in region 3. In baz mutant cysts, the centrosomes accumulate at the anterior of the oocyte but never move to the posterior cortex. Furthermore, alpha-tubulin stainings of mutant cysts indicate that microtubules remain focused on the anterior of the oocyte and fail to rearrange. These phenotypes are identical to those produced by par-1 mutants, indicating that Bazooka and PAR-1 act in the same step in oocyte determination. Neither is necessary for the initial selection of the oocyte, because Orb and the centrosomes still become restricted to one cell, but they are required for the maintenance of oocyte fate, since the oocyte soon dedifferentiates and becomes a nurse cell. This failure to maintain oocyte identity correlates with a block in the movement of oocyte-specific factors and the centrosomes from the anterior to the posterior of the cell, suggesting that this early polarization is important for the further development of the oocyte (Huynh, 2001b).

PAR-6 has been shown to localize to the same protein complex as PAR-3 in C. elegans, Drosophila, and mammalian cells and is essential both for the localization and the function of this complex. In Drosophila, Bazooka and PAR-6 colocalize to the apical side of the embryonic ectoderm, where they are necessary for the maintenance of epithelial polarity, and both proteins are also inherited by the neuroblasts when they delaminate and are required for the basal localization of cell fate determinants during their asymmetric divisions. To test if Drosophila PAR-6 also functions with Bazooka during oogenesis, germline clones were generated of the par-6Delta226 allele, which is a deletion of the promoter, the start codon, and the first 121 amino acids of the protein and is therefore a strong loss of function mutation if not a null. The majority of mutant egg chambers appear small, oval-shaped, and contain 16 polyploid nurse cells and no oocyte, indicating that PAR-6 is also required for oocyte determination. Furthermore, Orb and the centrosomes accumulate in one cell at the posterior of the cyst, although with a slight delay compared to wild-type. Both remain at the anterior of the oocyte, however, and fail to translocate to the posterior pole. Thus, the loss of PAR-6 from the germline gives an identical phenotype to Bazooka and PAR-1. As is the case for bazooka germline clones, some of the par-6 mutant egg chambers escape the early arrest and go on to produce normal eggs. When the females are scored 2 days after eclosion, half of the egg chambers form a normal oocyte, and about a quarter still do so after 10 days. This increase in the penetrance of the phenotype with age shows that PAR-6 protein perdures for many days after the clones are produced. Consistent with this, PAR-6 appears to be unusually stable in the embryo; the protein can be detected throughout embryogenesis in zygotic par-6 null embryos, at levels that are only slightly lower than in wild-type. However, the continued presence of escapers after 10 days suggests that PAR-6 may not be essential for oocyte determination in all cases and that there may be redundant pathways that can partially compensate for its absence (Huynh, 2001b).

To investigate the relationships between Bazooka, PAR-6, and PAR-1 during oocyte determination, their localizations were analyzed in both wild-type and mutant germaria. In region 2a to region 3 of the germarium, Bazooka localizes around the ring canals, in a ring that is about twice the diameter of that formed by actin. This localization is very similar to that of the adherens junction components Shotgun (E-cadherin) and Armadillo. A double staining was therefore performed for Arm and Baz. Although Arm localizes to these rings before Bazooka in early region 2a, the two proteins colocalize from the middle of region 2a until region 3, when they both disappear. Bazooka also colocalizes with Shotgun and Armadillo in the zonula adherens of the embryonic epithelium, which provides a boundary between the apical and basolateral membrane domains. This raises the possibility that the Shotgun, Armadillo, and Bazooka rings in the germarium perform a similar function by marking the separation between an anterior and a posterior domain within the oocyte. It is unclear whether PAR-6 also localizes to these rings, since none of the available antibodies give any significant staining that disappears in par-6 null germline clones

These results show that PAR-1, Bazooka, and PAR-6 act in the same step in oocyte determination, providing the first example in Drosophila where these three homologs of C. elegans PAR proteins participate in the same process. Furthermore, mutants in all three genes disrupt the movement of oocyte-specific proteins and the centrosomes from the anterior to the posterior of the oocyte, which is the earliest visible sign of polarity within the oocyte. Given the role of these PAR proteins in other systems, it seems very likely that their primary function in the germarium is in the anterior-posterior polarization of the oocyte, and that the failure to maintain oocyte fate is a consequence of this defect (Huynh, 2001b).

It is intriguing that this very early anterior-posterior polarity of the Drosophila oocyte requires three of the PAR proteins that mediate the anterior-posterior polarization of the first cell division in C. elegans. Although this suggests that these proteins act in a conserved pathway for generating cell polarity in these two systems, the relationships between the localizations of these proteins are quite different in the Drosophila oocyte and C. elegans zygote. Thus, at least some aspects of their function are not conserved, and it will therefore be interesting to determine whether the downstream pathways that generate other cellular asymmetries in response to this polarity are related (Huynh, 2001b).

PAR-1 regulates the polarised microtubule cytoskeleton in the Drosophila follicular epithelium

The PAR-1 kinase plays a conserved role in cell polarity in C. elegans, Drosophila and mammals. The role of PAR-1 in epithelial polarity was investigated by generating null mutant clones in the Drosophila follicular epithelium. Large clones show defects in apicobasal membrane polarity, but small clones induced later in development usually have a normal membrane polarity. However, all cells that lack PAR-1 accumulate spectrin and F-actin laterally, and show a strong increase in the density of microtubules. This is consistent with the observation that the mammalian PAR-1 homologs, the MARKs, dramatically reduce the number of microtubules, when overexpressed in tissue culture cells. The MARKs have been proposed to destabilize microtubules by inhibiting the stabilizing activity of the Tau family of microtubule-associated proteins. This is not the case in Drosophila, however, since null mutations in the single tau family member in the genome have no effect on the microtubule organization in the follicle cells. Furthermore, PAR-1 activity stabilizes microtubules: microtubules in mutant cells depolymerize much more rapidly after cold or colcemid treatments. Loss of PAR-1 also disrupts the basal localization of the microtubule plus ends, which are mislocalized to the center of mutant cells. Thus, Drosophila PAR-1 regulates the density, stability and apicobasal organization of microtubules. Although the direct targets of PAR-1 are unknown, it is suggested that it functions by regulating the plus ends, possibly by capping them at the basal cortex (Doerflinger, 2003).

Although par-1 mutants produce similar polarity phenotypes in the follicle cells to mutants in the components of the Bazooka/PAR-6/aPKC complex, they are not identical. par-1 clones cause a complete disruption of polarity only when induced early in the follicle cell lineage. The smaller clones that arise later in oogenesis often show little or no reduction in the localization of apical and basolateral markers, and usually remain as a single layer of cells. By contrast, even late clones of bazooka or aPKC produce penetrant epithelial defects. This difference is also apparent in the embryo, where loss of zygotic bazooka, PAR-6 or aPKC disrupts epithelial organization. par-1 homozygous embryos, however, display no obvious epithelial polarity phenotype, although it is not possible to remove the maternal PAR-1 completely. The reason for low penetrance of polarity defects in smaller par-1 follicle clones is unclear, but similar differences between early large clones and smaller late clones have been observed for crumbs and lkb1 (the Drosophila par-4 homolog - required for the early A-P polarity of the oocyte and for the repolarization of the oocyte cytoskeleton that defines the embryonic A-P axis). One possibility is that these genes are required for the initial formation of the follicular epithelium, but not for its maintenance. This seems unlikely to be the case for par-1, however, because small clones containing only one or two cells can sometimes show strong apicobasal polarity defects. A more likely explanation is that the low penetrance of this phenotype in small clones is due to the perdurance of the PAR-1 that was present at the time when the clones were induced. In support of this, the penetrance of the polarity defects of par-1 clones increases with clone size and the stage of oogenesis, as one would expect if the protein is gradually degraded over time, and is diluted out by cell division (Doerflinger, 2003).

In contrast to apicobasal membrane polarity, the density, the stability and the organization of MTs are disrupted in all par-1 clones, regardless of their size or the stage of oogenesis. This is likely to represent a distinct function of the kinase from its other roles in cell polarity, because it is much more sensitive to a reduction in activity. The effects of PAR-1 on MT density are consistent with results on the mammalian PAR-1 homologs, MARK1 and MARK2. These experiments show that removal of PAR-1 causes an increase in the density of MTs in each cell, whereas overexpression of MARK1 or MARK2 in unpolarized tissue culture cells causes most MTs to disappear (Doerflinger, 2003).

The MARKs have been proposed to regulate the MT cytoskeleton by phosphorylating Tau family MAPs, thereby inhibiting them from binding to and stabilizing MTs. Although PAR-1 does phosphorylate Drosophila Tau in vitro, tau null mutations are viable and fully fertile and have no effect on the arrangement of MTs in either the follicle cells or the oocyte. Therefore, this mechanism cannot account for its function in organizing the MTs in the follicle cells. The viability of tau mutants is surprising, given the many functions ascribed to Tau in human neurons. It does have a precedent, however, since tau knockout mice are viable, have a morphologically normal nervous system, and display only defects in MT stability and organisation in small-caliber axons. The mild phenotype of tau in mice has been proposed to be due to functional redundancy with the closely related MAP2, but this cannot be the case in Drosophila, which does not contain a MAP2 homolog. It may be redundant with other types of MAP, however, and the best candidate is Futsch, which has significant structural and functional homology to mammalian MAP1B. MAP1B appears to have functional overlap with both Tau and MAP2 in mammals, because mice that are homozygous for null mutations in map1b and tau, or map1b and map2, show defects in axonal elongation, neuronal migration and MT organization that are much more severe than in mice lacking only one of these genes (Doerflinger, 2003).

Another compelling argument that PAR-1 regulates MTs by a different mechanism from that proposed for the MARKs is that it is required to stabilize rather than destabilize MTs, at least in epithelial cells. The MTs in follicle cells are among the most stable in nature, because they are almost completely resistant to cold or to prolonged colchicine treatments. By contrast, the MTs in par-1 mutant cells appear to be highly dynamic because: (1) they disappear after brief colchicine treatments; (2) they depolymerize at 4°C, but re-grow in a few minutes after return to 25°C; (3) they are lost during fixation, if the fixative is too weak (Doerflinger, 2003).

The opposite effects of PAR-1 and the MARKs on MT stability may indicate that these closely related kinases have evolved to fulfil distinct functions in invertebrates and mammals. It is also possible, however, that this reflects the different experimental approaches and cell-types that have been used to examine their activities. The MARKs have been assayed by over-expressing them in CHO cells, which are a transformed line of rapidly dividing, undifferentiated and unpolarized cells. By contrast, the loss-of-function phenotype of PAR-1 was examined in post-mitotic follicle cells, highly polarized and differentiated epithelial cells. The two cell types also have very different microtubule cytoskeletons. In CHO cells, microtubules are nucleated from a central centrosome, and are presumably reasonably dynamic, because they disassemble at each mitosis, whereas the follicle cells lose their centrosomes when they form a columnar epithelium, and nucleate a very stable apicobasal array of microtubules. It would therefore be interesting to test the effects on MT stability of disrupting the function of PAR-1 homologs in more similar mammalian cell-types, such as polarized MDCK cells (Doerflinger, 2003).

In addition to its effect on stability, PAR-1 is required to maintain the normal organization of the MTs. The MT arrangement in the follicle cells is typical of a polarized epithelium, with the minus ends associated with the apical membrane, and the plus ends at the basal side of the cell. The arrangement of minus ends appears to be largely unchanged in par-1 mutant cells, but a marker for the plus ends, Kinesin:ß-gal, accumulates in the center rather than the basal region of the cell. This phenotype is very similar to that observed in par-1 mutant oocytes, in which the plus ends become abnormally focussed in the center of the oocyte, rather than at the posterior, and there is an increase in the density of MTs around the cortex. Thus, PAR-1 may regulate the MTs in the same way in the two cell types, and most probably acts primarily on the plus ends. PAR-1 may also have some effect on the distribution of the minus ends of MT in the oocyte, as bicoid mRNA, which is believed to be transported towards minus ends, is found around the lateral cortex of mutant oocytes, rather exclusively at the anterior. Although the possibility that there is also an effect on the minus ends in mutant follicle cells cannot be ruled out, this is not detectable using Nod:ß-gal (Nod is a kinesin-related protein) as a marker (Doerflinger, 2003).

It seems paradoxical that the loss of PAR-1 should increase the density of MTs in follicle cells, while decreasing their stability, but one possible explanation is suggested by studies in mammalian cells on populations of stable MTs that are marked by detyrosinated alpha-tubulin. These MTs are resistant to nocadazole-induced depolymerization, and fail to incorporate new tubulin subunits, leading to the proposal that they are capped at their plus ends in a way that prevents both the addition and loss of tubulin. Thus, it is possible that PAR-1 stabilises the MTs in the follicle cells by capping plus ends when they reach the basal cortex, thereby preventing them from either growing or shrinking. If the conditions inside the cell favour MT polymerization, the loss of the PAR-1-dependent cap would allow the plus ends to continue to grow once they reach the basal cortex. This could account for both the increase in MT density and the redistribution of plus ends to the center of mutant cells. However, the uncapped MTs would rapidly shrink under conditions that favor MT depolymerization, such as cold or colchicine treatment, explaining why the MTs disappear in mutant cells (Doerflinger, 2003).

par-1 null clones also show fully penetrant and cell-autonomous increases in the recruitment of ß-spectrin and actin to the lateral cortex. Like the microtubule phenotype, these effects appear to be independent of the defect in apicobasal membrane polarity, since the latter is much less penetrant. These phenotypes may therefore reflect a third distinct function of the kinase. It is also possible, however, that the MT defects are a consequence of the changes in actin organization or vice versa. In this context, it is interesting to note that Rho family GTPases, major regulators of the actin cytoskeleton, have also recently been found to control the capping of MT plus ends at the leading edge of migrating cells. The Rac and Cdc42 effector, IQGAP, interacts with the plus end binding protein, CLIP170, to stabilize MTs transiently, whereas the Rho effector, mDia, leads to the formation of more stable MTs, perhaps through the plus-end binding protein EB1. Given that PAR-1 does not appear to function through the obvious candidate, Tau, it would be interesting to test whether this kinase acts through either of these pathways to regulate MT organization in epithelial cells (Doerflinger, 2003).


REFERENCES

Benton, R., Palacios, I. M. and St Johnston, D. (2002). Drosophila 14-3-3/PAR-5 is an essential mediator of PAR-1 function in axis formation. Developmental Cell 3: 659-671. Medline abstract: 12431373

Biernat, J., et al. (2002). Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity. Mol. Biol. Cell. 13(11): 4013-28. Medline abstract: 12429843

Blot, J., et al. (2002). Cell cycle regulation of pEg3, a new Xenopus protein kinase of the KIN1/PAR-1/MARK family. Dev. Biol. 241(2): 327-38. Medline abstract: 11784115

Bohm, H., et al. (1997). Mammalian homologues of C. elegans PAR-1 are asymmetrically localized in epithelial cells and may influence their polarity. Curr. Biol. 7(8): 603-6. Medline abstract: 97411154

Bowerman B., et al. (1993). The maternal gene skn-1 encodes a protein that is distributed unequally in early C. elegans embryos. Cell 74(3): 443-52. Medline abstract: 93351225

Bowerman, B., Ingram, M. K. and Hunter, C. P. (1997). The maternal par genes and the segregation of cell fate specification activities in early Caenorhabditis elegans embryos. Development 124(19): 3815-26. Medline abstract: 98033260

Boyd, L., et al. (1996). PAR-2 is asymmetrically distributed and promotes association of P granules and PAR-1 with the cortex in C. elegans embryos. Development 122(10): 3075-84. Medline abstract: 97053807

Chang, H. C. and Rubin, G. M. (1997). 14-3-3 epsilon positively regulates Ras-mediated signaling in Drosophila. Genes Dev. 11: 1132-1139. Medline abstract: 9159394

Cox, D. N., et al. (2001). Drosophila par-1 is required for oocyte differentiation and microtubule organization. Curr. Biol. 11: 75-87. Medline abstract: 11231123

Crittenden, S. L., et al. (1997). Genes required for GLP-1 asymmetry in the early Caenorhabditis elegans embryo. 5: Dev. Biol. 181(1): 36-46. Medline abstract: 97167645

Cuenca, A. A., et al. (2003). Polarization of the C. elegans zygote proceeds via distinct establishment and maintenance phases. Development 130: 1255-1265. Medline abstract: 12588843

Doerflinger, H., et al. (2003). The role of PAR-1 in regulating the polarised microtubule cytoskeleton in the Drosophila follicular epithelium. Development 130: 3965-3975. Medline abstract: 12874119

Drewes G., et al. (1995). Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262. J. Biol. Chem. 270(13): 7679-88. Medline abstract: 95221434

Drewes G., et al. (1997). MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell 89(2): 297-308. Medline abstract: 97262070

Drewes, G. and Nurse, P. (2003). The protein kinase kin1, the fission yeast orthologue of mammalian MARK/PAR-1, localises to new cell ends after mitosis and is important for bipolar growth. FEBS Lett. 554(1-2): 45-9. Medline abstract: 14596912

Ebneth, A., Drewes, G. and Mandelkow, E. (1999). Phosphorylation of MAP2c and MAP4 by MARK kinases leads to the destabilization of microtubules in cells. Cell Motil. Cytoskeleton 44(3): 209-24. Medline abstract: 20011319

Etemad-Moghadam, B., Guo, S. and Kemphues, K. J. (1995). Asymmetrically distributed PAR-3 protein contributes to cell polarity and spindle alignment in early C. elegans embryos. Cell 83(5): 743-52. Medline abstract: 96097118

Guo, S. and Kemphues, K. J. (1995). par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell 81(4): 611-20. Medline abstract: 95277848

Guo, S. and Kemphues, K. J. (1996). A non-muscle myosin required for embryonic polarity in Caenorhabditis elegans. Nature 382(6590): 455-8. Medline abstract: 96310865

Heidary, G. and Fortini, M.E. (2001). Identification and characterization of the Drosophila tau homolog. Mech. Dev. 108: 171-178. Medline abstract: 11578871

Huang, N. M., et al. (2002). MEX-3 interacting proteins link cell polarity to asymmetric gene expression in Caenorhabditis elegans. Development 129: 747-759. Medline abstract: 11830574

Hurd, D. D. and Kemphues, K. J. (2003). PAR-1 is required for morphogenesis of the Caenorhabditis elegans vulva. Dev. Biol. 253(1): 54-65. Medline abstract: 12490197

Huynh, J.-R., et al. (2001a). PAR-1 is required for the maintenance of oocyte fate in Drosophila. Development 128: 1201-1209. Medline abstract: 11245586

Huynh, J. R., et al. (2001b). Bazooka and PAR-6 are required with PAR-1 for the maintenance of oocyte fate in Drosophila. Cur. Biol. 11: 901-906. Medline abstract: 11245586

Illenberger, S., et al. (1996). Phosphorylation of microtubule-associated proteins MAP2 and MAP4 by the protein kinase p110mark. Phosphorylation sites and regulation of microtubule dynamics. J. Biol. Chem. 271(18): 10834-43. Medline abstract: 96210020

Jackson, G. R., Wiedau-Pazos, M., Sang, T. K., Wagle, N., Brown, C. A., Massachi, S. and Geschwind, D. H. (2002). Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34: 509-519. Medline abstract: 12062036

Jenkins, S. M. and Johnson, G. V. (2000). Microtubule/MAP-affinity regulating kinase (MARK) is activated by phenylarsine oxide in situ and phosphorylates tau within its microtubule-binding domain. J. Neurochem. 74(4): 1463-8. Medline abstract: 20199863

Kemphues, K. J., et al. (1988). Identification of genes required for cytoplasmic localization in early C. elegans embryos. Cell 52: 311-20. Medline abstract: 88151036

Levin, D. E. and Bishop, J. M. (1990). A putative protein kinase gene (kin1+) is important for growth polarity in Schizosaccharomyces pombe. Proc. Natl. Acad. Sci. 87(21): 8272-6. Medline abstract: 91045979

Nelson, W. J. and Grindstaff, K. K. (1997). Cell polarity: par for the polar course. Curr. Biol. 7: R562-4. Medline abstract: 97431712

Nishimura, I., Yang, Y. and Lu, B. (2004). PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers Tau toxicity in Drosophila. Cell 116: 671-682. Medline abstract: 15006350

Rappleye, C. A., et al. (1999). The coronin-like protein POD-1 is required for anterior-posterior axis formation and cellular architecture in the nematode Caenorhabditis elegans. Genes Dev. 13: 2838-51. Medline abstract: 20026163

Riechmann, V., Gutierrez, G. J., Filardo, P., Nebreda, A. R. and Ephrussi, A. (2002). Par-1 regulates stability of the posterior determinant Oskar by phosphorylation. Nat. Cell Biol. 4: 337-342. Medline abstract: 11951092

Schneider A., et al. (1999). Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Biochemistry 38(12): 3549-58. Medline abstract: 99192391

Shulman, J. M., Benton, R. and St Johnston, D. (2000). The Drosophila homolog of C. elegans PAR-1 organizes the oocyte cytoskeleton and directs oskar mRNA localization to the posterior pole. Cell 101: 377–388. Medline abstract: 20288977

Sun, T. Q., et al. (2001). PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling. Nature Cell Bio. 3: 628-636. Medline abstract: 11433294

Timm, T., et al. (2003). MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK/PAR-1. EMBO J. 22(19): 5090-101. Medline abstract: 14517247

Tomancak, P., et al. (2000). A Drosophila melanogaster homologue of Caenorhabditis elegans par-1 acts at an early step in embryonic-axis formation. Nature Cell Biol. 2: 458-460. Medline abstract: 10878812

Trinczek, B., et al. (2003). MARK4 is a novel MAP/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes. J. Biol. Chem. Medline abstract: 14594945

Vaccari, T. and Ephrussi, A. (2002). The fusome and microtubules enrich, Par-1 in the oocyte, where it effects polarization in conjunction with Par-3, BicD, Egl, and Dynein. Curr. Biol. 12: 1524-1528. Medline abstract: 12225669


par-1: Biological Overview | Evolutionary Homologs | Regulation | Developmental Biology | Effects of Mutation

date revised: 10 July 2004

Home page: The Interactive Fly © 1997 Thomas B. Brody, Ph.D.

Please e-mail comments/corrections to brodyt@codon.nih.gov


Send comments to us at flybase-help AT morgan.harvard.edu
FlyBase-NG uses Argos: A Replicable Genome infOrmation System